ST JUDE CHILDRENS RESEARCH HOSPITAL INC: Form 990, tax year 2016
View the entire original 990 at ProPublica ↗
- Organization
- ST JUDE CHILDRENS RESEARCH HOSPITAL INC (EIN 62-0646012)
- Tax period
- 2016-07-01 to 2017-06-30
- Filed
- 2018-05-03
- IRS object ID
- 201831239349301983
- Schema version
- 2016v3.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule H
- Schedule I
- Schedule J
- Schedule L
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2018-05-03T20:36:28-05:00 | ReturnTs |
| Tax Period End | 2017-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 861065772 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | DELOITTE TAX LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1033 DEMONBREUN SUITE 400 | AddressLine1Txt |
| City | NASHVILLE | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 37203 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2016-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 620646012 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ST JUDE CHILDREN'S RESEARCH HOSPITAL | BusinessNameLine1Txt |
| Business Name Line2 | INC | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | STJU | BusinessNameControlTxt |
| Phone | 9015953903 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 262 DANNY THOMAS PLACE | AddressLine1Txt |
| City | MEMPHIS | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 381053678 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | PAT KEEL | PersonNm |
| Person Title | SVP AND CFO | PersonTitleTxt |
| Phone | 9015953903 | PhoneNum |
| Signature | 2018-05-03 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | FRAN BEDARD | PreparerPersonNm |
| PTIN | P00752421 | PTIN |
| Phone | 6152591800 | PhoneNum |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 99.169.247.132 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IP | 2018-05-03 | IPDt |
| IP Tm | 20:11:05 | IPTm |
| IP Timezone | ED | IPTimezoneCd |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | 5CFFDD8923AB131445275696BFBBD59E6AC5F298 | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | 31FE60C2ABD567A878DE2EF8F6F522EFC42D780D | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2016 | TaxYr |
| Build TS | 2021-01-29 14:40:06Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | JAMES R DOWNING | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 262 DANNY THOMAS PLACE | AddressLine1Txt |
| City | MEMPHIS | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 381053678 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $902,595,854 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.STJUDE.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1959 | FormationYr |
| Legal Domicile State | TN | LegalDomicileStateCd |
| Activity Or Mission | THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT. CONSISTENT WITH THE VISION OF OUR FOUNDER DANNY THOMAS, NO CHILD IS DENIED TREATMENT BASED ON RACE, RELIGION OR A FAMILY'S ABILITY TO PAY. | ActivityOrMissionDesc |
| Voting Members Governing Body | 43 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 41 | VotingMembersIndependentCnt |
| Total Employee | 4929 | TotalEmployeeCnt |
| Total Volunteers | 3506 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $895,523,715 | PYContributionsGrantsAmt |
| CY Contributions Grants | $753,145,680 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $114,471,276 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $124,099,314 | CYProgramServiceRevenueAmt |
| PY Investment Income | -$931,340 | PYInvestmentIncomeAmt |
| CY Investment Income | -$1,169,284 | CYInvestmentIncomeAmt |
| PY Other Revenue | $18,454,213 | PYOtherRevenueAmt |
| CY Other Revenue | $24,726,224 | CYOtherRevenueAmt |
| PY Total Revenue | $1,027,517,864 | PYTotalRevenueAmt |
| CY Total Revenue | $900,801,934 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $3,804,019 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $4,956,619 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $426,318,943 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $462,005,025 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $367,096,278 | PYOtherExpensesAmt |
| CY Other Expenses | $390,060,200 | CYOtherExpensesAmt |
| PY Total Expenses | $797,219,240 | PYTotalExpensesAmt |
| CY Total Expenses | $857,021,844 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $230,298,624 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $43,780,090 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $4,292,347,585 | TotalAssetsBOYAmt |
| Total Assets EOY | $4,787,635,534 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $334,430,658 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $127,718,358 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $3,957,916,927 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $4,659,917,176 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT. CONSISTENT WITH THE VISION OF OUR FOUNDER DANNY THOMAS, NO CHILD IS DENIED TREATMENT BASED ON RACE, RELIGION OR A FAMILY'S ABILITY TO PAY. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $427,944,725 | ExpenseAmt |
| Grant | $4,863,669 | GrantAmt |
| Revenue | $130,698,282 | RevenueAmt |
| Desc | PATIENT CARE: THE HOSPITAL PROVIDED 19,732 INPATIENT DAYS OF CARE DURING THE YEAR. OUR BONE MARROW TRANSPLANTATION PROGRAM ACCOUNTED FOR 4,704 OR 24% OF THOSE INPATIENT DAYS. PATIENTS MADE 78,587 CLINIC VISITS DURING THE YEAR. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $368,333,510 | ExpenseAmt |
| Grant | $92,950 | GrantAmt |
| Desc | RESEARCH: THE CURRENT BASIC SCIENCE AND CLINICAL RESEARCH AT THE HOSPITAL INCLUDES WORK IN GENE THERAPY, CHEMOTHERAPY, THE BIOCHEMISTRY OF NORMAL AND CANCEROUS CELLS, RADIATION TREATMENT, BLOOD DISEASES, RESISTANCE TO THERAPY, VIRUSES, HEREDITARY DISEASES, INFLUENZA, PEDIATRIC AIDS AND PHYSIOLOGICAL EFFECTS OF CATASTROPHIC ILLNESSES. THE HOSPITAL AWARDS NO GRANTS TO OUTSIDE AGENCIES. ALL RESEARCH ACTIVITIES ARE CONDUCTED BY HOSPITAL PERSONNEL. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $15,778,174 | ExpenseAmt |
| Desc | EDUCATION AND TRAINING: AS PART OF ITS MISSION, THE HOSPITAL HAS DEVELOPED A GLOBAL INITIATIVE (ST. JUDE GLOBAL) TO IMPROVE THE SURVIVAL RATES OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES WORLDWIDE. ST. JUDE GLOBAL ACCOMPLISHES THIS BY SHARING KNOWLEDGE, TECHNOLOGY AND ORGANIZATIONAL SKILLS, IMPLEMENTING NEW APPROACHES TO TREAT PEDIATRIC CANCER GLOBALLY, AND GENERATING INTERNATIONAL NETWORKS COMMITTED TO ERADICATING CANCER IN CHILDREN. THESE INITIATIVES ARE SPEARHEADED BY ST. JUDE EXPERTS WHO WORK CLOSELY WITH HEALTHCARE PROFESSIONALS AT OUR PARTNER SITES. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $812,056,409 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (1) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (1) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | Yes (1) | OperateHospitalInd |
| Audited Financial Stmt Att | Yes (1) | AuditedFinancialStmtAttInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | Yes (1) | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | 0 | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | Yes (1) | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 1144 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 4929 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 43 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 41 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | Yes (1) | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | Yes (1) | LocalChaptersInd |
| Policies Reference Chapters | Yes (1) | PoliciesReferenceChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | SHARON HENDRIX | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 9015953903 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 262 DANNY THOMAS PLACE | AddressLine1Txt |
| City | MEMPHIS | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 381053678 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (57 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd |
|---|---|---|---|---|---|---|---|---|---|
| JOYCE ABOUSSIE | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| SUSAN MACK AGUILLARD MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| MAHIR AWDEH MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| JOSEPH S AYOUB JR ESQ | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| PAUL J AYOUB ESQ | |||||||||
| VOTING DIRECTOR | 4.00 | 8.00 | Yes (X) | $0 | $0 | $0 | |||
| FREDERICK M AZAR MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| JAMES B BARKATE | |||||||||
| VOTING DIRECTOR | 4.00 | 8.00 | Yes (X) | $0 | $0 | $0 | |||
| MARTHA PERINE BEARD | |||||||||
| VOTING DIRECTOR | 8.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| SHERYL BOURISK | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| ROBERT A BREIT MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| TERRY BURMAN | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| ANN M DANNER | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| JOSEPH M DEVIVO | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| FRED P GATTAS III PHARMD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| RUTH GAVIRIA | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| CHRISTOPHER GEORGE MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| JUDY HABIB | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| GABRIEL GABY HADDAD MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| PAUL K HAJAR | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| CHUCK HAJJAR | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| FOUAD HAJJAR MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| FREDERICK R HARRIS | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| FREDERICK R HARRIS JR MD | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| BRUCE B HOPKINS | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| J DAVID KARAM II | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| MICHAEL D MCCOY | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| ROBERT T MOLINET ESQ | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| JAMES NAIFEH JR | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| RAMZI NUWAYHID | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| THOMAS PENN III | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| CAMILLE F SARROUF JR ESQ | |||||||||
| VOTING DIRECTOR | 8.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| JOSEPH C SHAKER | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| JOSEPH G SHAKER | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| GEORGE A SIMON II | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| MICHAEL SIMON | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| PAUL J SIMON | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| TONY THOMAS | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| RICHARD M UNES | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| PAUL H WEIN ESQ | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| THOMAS WERTZ | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| TAMA ZAYDON | |||||||||
| VOTING DIRECTOR | 4.00 | 4.00 | Yes (X) | $0 | $0 | $0 | |||
| RICHARD SHADYAC JR | |||||||||
| EX-OFFICIO DIRECTOR | 1.00 | 55.00 | Yes (X) | $0 | $772,284 | $96,359 | |||
| JAMES R DOWNING | |||||||||
| PRESIDENT & CEO, EX-OFFICIO DIRECTOR | 55.00 | 1.00 | Yes (X) | $1,039,955 | $0 | $47,189 | Yes (X) | ||
| PAT KEEL | |||||||||
| SVP/CFO | 55.00 | 0.00 | $598,921 | $0 | $30,147 | Yes (X) | |||
| JAMES I MORGAN | |||||||||
| EVP/SCIENTIFIC DIRECTOR | 55.00 | 0.00 | $594,267 | $0 | $49,630 | Yes (X) | |||
| ELLIS NEUFELD | |||||||||
| EVP/CLINICAL DIR (BEGAN 2/7/17) | 55.00 | 0.00 | $0 | $0 | $0 | Yes (X) | |||
| MARY ANNA QUINN | |||||||||
| EVP/CHIEF ADMIN OFFICER | 55.00 | 0.00 | $665,750 | $0 | $71,119 | Yes (X) | |||
| CHARLES M ROBERTS | |||||||||
| EVP/DIRECTOR CANCER CENTER | 55.00 | 0.00 | $750,846 | $0 | $143,369 | Yes (X) | |||
| CARLOS RODRIGUEZ-GALINDO | |||||||||
| EVP/CHAIR | 55.00 | 0.00 | $757,311 | $0 | $36,096 | Yes (X) | |||
| DAVID ELLISON | |||||||||
| CHAIR | 55.00 | 0.00 | $869,626 | $0 | $69,223 | Yes (X) | |||
| THOMAS E MERCHANT | |||||||||
| CHAIR | 55.00 | 0.00 | $1,190,070 | $0 | $59,558 | Yes (X) | |||
| CHING-HON PUI | |||||||||
| CHAIR | 55.00 | 0.00 | $923,008 | $0 | $79,222 | Yes (X) | |||
| LESLIE L ROBISON | |||||||||
| CHAIR | 55.00 | 0.00 | $879,554 | $0 | $47,130 | Yes (X) | |||
| ELAINE I TUOMANEN | |||||||||
| CHAIR | 55.00 | 0.00 | $750,272 | $0 | $44,184 | Yes (X) | |||
| MICHAEL C CANARIOS | |||||||||
| FORMER SVP/CHIEF FINANCIAL OFFICER | 0.00 | 0.00 | $466,200 | $0 | $17,363 | Yes (X) | |||
| WILLIAM E EVANS | |||||||||
| FACULTY/FORMER PRES. & CEO | 55.00 | 0.00 | $678,640 | $0 | $37,822 | Yes (X) | |||
| LARRY KUN | |||||||||
| FORMER EVP/CLINICAL DIRECTOR | 55.00 | 0.00 | $524,216 | $0 | $39,155 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $10,688,636 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $772,284 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $867,566 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 766 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (1) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| FLINTCO LLC | |||||
| 2179 HILLSHIRE CIRCLE | MEMPHIS | TN | 38133 | CONSTRUCTION CONTRACTOR | $37,621,274 |
| BELZ CONSTRUCTION SERVICES | |||||
| 100 PEABODY PLACE SUITE 1400 | MEMPHIS | TN | 38103 | CONSTRUCTION CONTRACTOR | $8,869,892 |
| UNIVERSITY OF TENNESSEE | |||||
| 62 SOUTH DUNLAP SUITE 300 | MEMPHIS | TN | 38163 | MEDICAL SERVICES | $8,402,521 |
| METHODIST HEALTHCARE MEMPHIS | |||||
| 1265 UNION AVE | MEMPHIS | TN | 38104 | MEDICAL SERVICES | $6,751,458 |
| PHILIPS HEALTHCARE | |||||
| 3000 MINUTEMAN RD MS2214 | ANDOVER | MA | 01810 | MAINTENANCE SERVICES | $5,793,524 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 215 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $663,714,692 | RelatedOrganizationsAmt |
| Government Grants | $79,430,395 | GovernmentGrantsAmt |
| All Other Contributions | $10,000,593 | AllOtherContributionsAmt |
| Total Contributions | $753,145,680 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | PATIENT CARE | Desc |
| Business | 621110 | BusinessCd |
| Total Revenue Column | $124,099,314 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $124,099,314 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $124,099,314 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $53,778 | TotalRevenueColumnAmt |
| Exclusion | $53,778 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $4,587,763 | TotalRevenueColumnAmt |
| Exclusion | $4,587,763 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $532,943 | SecuritiesAmt |
| Other | $37,915 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $455,214 | SecuritiesAmt |
| Other | $1,338,706 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $77,729 | SecuritiesAmt |
| Other | -$1,300,791 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$1,223,062 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | -$1,300,791 | RelatedOrExemptFuncIncomeAmt |
| Exclusion | $77,729 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|---|
| BOND DEFEASANCE GAIN | 900099 | $8,152,422 | $8,152,422 | |
| CAFETERIA/VENDING | 722514 | $4,086,280 | $4,086,280 | |
| CHGME/CHCA | 900099 | $2,058,124 | $2,058,124 |
Miscellaneous Revenue MiscellaneousRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $5,841,635 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $5,841,635 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $20,138,461 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $900,801,934 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $130,698,282 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $16,957,972 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,956,619 | TotalAmt |
| Program Services | $4,956,619 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,847,287 | TotalAmt |
| Program Services | $2,862,030 | ProgramServicesAmt |
| Management And General | $2,985,257 | ManagementAndGeneralAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,007,480 | TotalAmt |
| Program Services | $788,139 | ProgramServicesAmt |
| Management And General | $219,341 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $355,728,362 | TotalAmt |
| Program Services | $329,928,888 | ProgramServicesAmt |
| Management And General | $25,799,474 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $22,068,722 | TotalAmt |
| Program Services | $20,468,171 | ProgramServicesAmt |
| Management And General | $1,600,551 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $52,835,044 | TotalAmt |
| Program Services | $49,003,142 | ProgramServicesAmt |
| Management And General | $3,831,902 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $24,518,130 | TotalAmt |
| Program Services | $22,739,934 | ProgramServicesAmt |
| Management And General | $1,778,196 | ManagementAndGeneralAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $22,053,885 | TotalAmt |
| Program Services | $20,952,761 | ProgramServicesAmt |
| Management And General | $1,101,124 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,306,008 | TotalAmt |
| Program Services | $2,190,872 | ProgramServicesAmt |
| Management And General | $115,136 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $249,522 | TotalAmt |
| Program Services | $237,064 | ProgramServicesAmt |
| Management And General | $12,458 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $44,215 | TotalAmt |
| Management And General | $44,215 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $78,481,617 | TotalAmt |
| Program Services | $69,646,578 | ProgramServicesAmt |
| Management And General | $8,835,039 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $806,218 | TotalAmt |
| Program Services | $765,965 | ProgramServicesAmt |
| Management And General | $40,253 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,535,016 | TotalAmt |
| Program Services | $2,492,051 | ProgramServicesAmt |
| Management And General | $42,965 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $21,817,392 | TotalAmt |
| Program Services | $20,728,076 | ProgramServicesAmt |
| Management And General | $1,089,316 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $30,352,986 | TotalAmt |
| Program Services | $27,126,463 | ProgramServicesAmt |
| Management And General | $3,226,523 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $11,294,999 | TotalAmt |
| Program Services | $10,723,676 | ProgramServicesAmt |
| Management And General | $571,323 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,876,999 | TotalAmt |
| Program Services | $1,456,156 | ProgramServicesAmt |
| Management And General | $420,843 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $77,810,083 | TotalAmt |
| Program Services | $74,037,738 | ProgramServicesAmt |
| Management And General | $3,772,345 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,576,077 | TotalAmt |
| Program Services | $1,163,902 | ProgramServicesAmt |
| Management And General | $412,175 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| PHARMACEUTICAL SUPPLIES | $56,705,552 | $55,744,479 | $961,073 |
| LABORATORY SUPPLIES | $40,496,773 | $39,810,415 | $686,358 |
| TELEPHONE | $1,399,353 | $1,213,498 | $185,855 |
| ALLOCATION ADJUSTMENTS | $0 | $17,568,038 | -$17,568,038 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $40,253,505 | TotalAmt |
| Program Services | $35,451,754 | ProgramServicesAmt |
| Management And General | $4,801,751 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $857,021,844 | TotalAmt |
| Program Services | $812,056,409 | ProgramServicesAmt |
| Management And General | $44,965,435 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $26,610 | BOYAmt |
| EOY | $21,110 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $207,132,006 | BOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,181,367 | BOYAmt |
| EOY | $20,889,800 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $21,496,532 | BOYAmt |
| EOY | $19,183,301 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,178,927 | BOYAmt |
| EOY | $7,505,346 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,966,158 | BOYAmt |
| EOY | $16,177,850 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $1,448,743,860 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $809,864,922 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $599,678,476 | BOYAmt |
| EOY | $638,878,938 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,822,937 | BOYAmt |
| EOY | $2,045,240 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,425,864,572 | BOYAmt |
| EOY | $4,082,933,949 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,292,347,585 | BOYAmt |
| EOY | $4,787,635,534 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $109,714,635 | BOYAmt |
| EOY | $113,161,164 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,792,331 | BOYAmt |
| EOY | $11,299,828 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $211,247,710 | BOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,675,982 | BOYAmt |
| EOY | $3,257,366 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $334,430,658 | BOYAmt |
| EOY | $127,718,358 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,019,955,372 | BOYAmt |
| EOY | $3,620,941,222 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $64,904,956 | BOYAmt |
| EOY | $73,722,532 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $873,056,599 | BOYAmt |
| EOY | $965,253,422 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,957,916,927 | BOYAmt |
| EOY | $4,659,917,176 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,292,347,585 | BOYAmt |
| EOY | $4,787,635,534 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $43,780,090 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $135,494 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $658,084,665 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consol And Sep Basis Fincl Stmt | Yes (X) | ConsolAndSepBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Hospital | Yes (X) | HospitalInd |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $581,788,213 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $611,432,510 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $674,808,276 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $895,523,715 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $753,145,680 | CurrentTaxYearAmt |
| Total | $3,516,698,394 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $581,788,213 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $611,432,510 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $674,808,276 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $895,523,715 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $753,145,680 | CurrentTaxYearAmt |
| Total | $3,516,698,394 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total170 | $3,516,698,394 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $3,291,661 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $24,413,935 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $7,579,828 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $11,681,881 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $4,641,541 | CurrentTaxYearAmt |
| Total | $51,608,846 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $7,012,056 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $8,697,307 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $7,390,478 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $6,775,862 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $20,138,461 | CurrentTaxYearAmt |
| Total | $50,014,164 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $3,618,321,404 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $545,582,792 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.97190 | PublicSupportCY170Pct |
| Public Support PY170 | 0.97510 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART II, SECTION B, LINE 10: | FormAndLineReferenceDesc |
| Explanation | EXPLANATION FOR OTHER INCOME: 2012 $ 3,119,452 - CAFETERIA/VENDING $ 1,112,814 - CHGME/CHCA $ 2,779,790 - OTHER REVENUE $ 7,012,056 - TOTAL OTHER INCOME 2013 $ 3,314,275 - CAFETERIA/VENDING $ 1,955,292 - CHGME/CHCA $ 3,427,740 - OTHER REVENUE $ 8,697,307 - TOTAL OTHER INCOME 2014 $ 3,534,638 - CAFETERIA/VENDING $ 1,454,365 - CHGME/CHCA $ 2,401,475 - OTHER REVENUE $ 7,390,478 - TOTAL OTHER INCOME 2015 $ 3,709,328 - CAFETERIA/VENDING $ 1,683,327 - CHGME/CHCA $ 1,383,207 - OTHER REVENUE $ 6,775,862 - TOTAL OTHER INCOME 2016 $ 8,152,422 - BOND DEFEASANCE GAIN $ 4,086,280 - CAFETERIA/VENDING $ 2,058,124 - CHGME/CHCA $ 5,841,635 - OTHER REVENUE $ 20,136,461- TOTAL OTHER INCOME | ExplanationTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | Yes (1) | VolunteersInd |
| Paid Staff Or Management | Yes (1) | PaidStaffOrManagementInd |
| Media Advertisements | 0 | MediaAdvertisementsInd |
| Mailings Members | 0 | MailingsMembersInd |
| Publications Or Broadcast | 0 | PublicationsOrBroadcastInd |
| Grants Other Organizations | 0 | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | Yes (1) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $19,189 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | 0 | RalliesDemonstrationsInd |
| Other Activities | Yes (1) | OtherActivitiesInd |
| Other Activities | $25,026 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $44,215 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | 0 | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART II-B, LINE 1: | FormAndLineReferenceDesc |
| Explanation | LINE 1A) A ST. JUDE PATIENT/FAMILY TRAVELED TO DC ON BEHALF OF ST. JUDE TO ADVOCATE WITH CONGRESS FOR INCREASED NIH FUNDING; LINE 1B) ST. JUDE EMPLOYS A DIRECTOR OF GOVERNMENT AFFAIRS; LINE 1G) AMOUNT LISTED IS PRORATED SALARY OF DIRECTOR OF GOVERNMENT AFFAIRS PLUS TRAVEL EXPENSES; LINE 1I) AMOUNT LISTED IS RELATED TO PRORATED RETAINER FEES FOR DIRECT AND STATE LEGISLATIVE CONTACTS AS WELL AS A PORTION OF PROFESSIONAL DUES ATTRIBUTABLE TO LOBBYING. | ExplanationTxt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $873,056,599 | BeginningYearBalanceAmt |
| Contributions | $12,552,432 | ContributionsAmt |
| Investment Earnings Or Losses | $103,475,245 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $23,830,854 | OtherExpendituresAmt |
| End Year Balance | $965,253,422 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $873,885,134 | BeginningYearBalanceAmt |
| Contributions | $2,341,719 | ContributionsAmt |
| Investment Earnings Or Losses | -$72,118 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $3,098,136 | OtherExpendituresAmt |
| End Year Balance | $873,056,599 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $915,104,075 | BeginningYearBalanceAmt |
| Contributions | $2,970,640 | ContributionsAmt |
| Investment Earnings Or Losses | $8,222,632 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $52,412,213 | OtherExpendituresAmt |
| End Year Balance | $873,885,134 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $843,843,273 | BeginningYearBalanceAmt |
| Contributions | $1,097,137 | ContributionsAmt |
| Investment Earnings Or Losses | $121,617,552 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $51,453,887 | OtherExpendituresAmt |
| End Year Balance | $915,104,075 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $782,714,653 | BeginningYearBalanceAmt |
| Contributions | $705,311 | ContributionsAmt |
| Investment Earnings Or Losses | $69,209,599 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $8,786,290 | OtherExpendituresAmt |
| End Year Balance | $843,843,273 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prmnnt Endowment Balance EOY | 1.00000 | PrmnntEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | Yes (1) | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | Yes (1) | EndowmentsHeldRelatedOrgInd |
| Related Org List Sch R | Yes (1) | RelatedOrgListSchRInd |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $1,023,680,309 | OtherCostOrOtherBasisAmt |
| Depreciation | $511,335,832 | DepreciationAmt |
| Book Value | $512,344,477 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $415,473,178 | OtherCostOrOtherBasisAmt |
| Depreciation | $292,841,681 | DepreciationAmt |
| Book Value | $122,631,497 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $9,590,373 | OtherCostOrOtherBasisAmt |
| Depreciation | $5,687,409 | DepreciationAmt |
| Book Value | $3,902,964 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $638,878,938 | TotalBookValueLandBuildingsAmt |
Other Assets Org OtherAssetsOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | INTEREST IN NET ASSETS OF AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES, INC | Desc |
| Book Value | $4,082,933,949 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $4,082,933,949 | TotalBookValueOtherAssetsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| SELF INSURANCE LIABILITY | $2,013,404 |
| WORKERS COMPENSATION | $1,243,962 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $3,257,366 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $786,140,580 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $135,494 | NetUnrealizedGainsInvstAmt |
| Other Revenue | $557,070,266 | OtherRevenueAmt |
| Revenue Not Reported | $557,205,760 | RevenueNotReportedAmt |
| Revenue Subtotal | $228,934,820 | RevenueSubtotalAmt |
| Other Revenues Not Included | $671,867,114 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | $671,867,114 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $900,801,934 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $857,021,844 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $857,021,844 | ExpensesSubtotalAmt |
| Expenses Not Rpt Fincl Stmt | $0 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $857,021,844 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART V, LINE 4: | THE ENDOWMENT FUNDS ARE HELD BY AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES, INC., A RELATED ORGANIZATION, AND ARE USED TO SUPPORT THE FUTURE NEEDS OF ST. JUDE. |
| PART X, LINE 2: | AS OF JUNE 30, 2017, THE ORGANIZATION HAD NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS UNDER ASC TOPIC 740, INCOME TAXES, REQUIRING ADJUSTMENTS TO ITS COMBINED FINANCIAL STATEMENTS. IN THE EVENT THE ORGANIZATION WERE TO RECOGNIZE INTEREST AND PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IT WOULD BE RECOGNIZED IN THE COMBINED FINANCIAL STATEMENTS AS A GENERAL EXPENSE. GENERALLY, TAX YEARS ENDING IN 2014 THROUGH 2017 ARE OPEN TO EXAMINATION BY THE FEDERAL AND STATE TAXING AUTHORITIES, RESPECTIVELY. THERE ARE NO INCOME TAX EXAMINATIONS CURRENTLY IN PROCESS. |
| PART XI, LINE 2D - OTHER ADJUSTMENTS: | CHANGE IN INTEREST IN UNRESTRICTED NET ASSETS - ALSAC 557,070,266. |
| PART XI, LINE 4B - OTHER ADJUSTMENTS: | CONTRIBUTION - SUPPORT RECEIVED FROM ALSAC 663,714,692. GAIN ON BOND DEFEASANCE 8,152,422. |
Schedule F IRS990ScheduleF
Account Activities Outside US AccountActivitiesOutsideUSGrp (8 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| CENTRAL AMERICA & THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $1,229,950 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $3,310,151 |
| EUROPE (INCLUDING ICELAND AND GREENLAND) | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | -$265,774 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $4,582,761 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | -$1,603 |
| RUSSIA AND NEIGHBORING STATES | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $1,313 |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $832,337 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | RESEARCH / EDUCATION AND TRAINING | $3,383 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continutation Total Office | 0 | ContinutationTotalOfficeCnt |
| Continutation Total Employee | 0 | ContinutationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $9,692,518 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $9,692,518 | TotalSpentAmt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 3: | FormAndLineReferenceDesc |
| Explanation | EXPENDITURES ARE RECORDED ON AN ACCRUAL BASIS. PAYMENTS ARE ISSUED BASED ON CONTRACTUAL OBLIGATIONS UPON RECEIPT OF SUPPORTING DOCUMENTATION. | ExplanationTxt |
Schedule H IRS990ScheduleH
| Field | Value | IRS element (for citing) |
|---|---|---|
| Financial Assistance Policy | Yes (1) | FinancialAssistancePolicyInd |
| Written Policy | Yes (1) | WrittenPolicyInd |
| FPG Reference Free Care | 0 | FPGReferenceFreeCareInd |
| FPG Reference Discounted Care | 0 | FPGReferenceDiscountedCareInd |
| Free Care Medically Indigent | Yes (1) | FreeCareMedicallyIndigentInd |
| Financial Assistance Budget | Yes (1) | FinancialAssistanceBudgetInd |
| Expenses Exceed Budget | Yes (1) | ExpensesExceedBudgetInd |
| Unable To Provide Care | 0 | UnableToProvideCareInd |
| Annual Community Bnft Report | 0 | AnnualCommunityBnftReportInd |
Financial Assistance At Cost Typ FinancialAssistanceAtCostTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $74,493,760 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $391,930 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $74,101,830 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.08650 | TotalExpensePct |
Unreimbursed Medicaid UnreimbursedMedicaidGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $152,099,836 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $33,008,786 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $119,091,050 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.13900 | TotalExpensePct |
Unreimbursed Costs UnreimbursedCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $8,522,000 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $1,838,368 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $6,683,632 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00780 | TotalExpensePct |
Total Financial Assistance Typ TotalFinancialAssistanceTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $235,115,596 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $35,239,084 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $199,876,512 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.23330 | TotalExpensePct |
Community Health Services CommunityHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $21,192,693 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $21,192,693 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.02470 | TotalExpensePct |
Health Professions Education HealthProfessionsEducationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $9,677,935 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $265,036 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $9,412,899 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.01100 | TotalExpensePct |
Subsidized Health Services SubsidizedHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $25,572,063 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $25,572,063 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.02980 | TotalExpensePct |
Research ResearchGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $334,430,853 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $77,926,736 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $256,504,117 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.29930 | TotalExpensePct |
Cash And In Kind Contributions CashAndInKindContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $4,726,935 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $4,726,935 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00550 | TotalExpensePct |
Total Other Benefits TotalOtherBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $395,600,479 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $78,191,772 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $317,408,707 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.37030 | TotalExpensePct |
Total Community Benefits TotalCommunityBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $630,716,075 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $113,430,856 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $517,285,219 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.60360 | TotalExpensePct |
Economic Development EconomicDevelopmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $85,532 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $85,532 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00010 | TotalExpensePct |
Health Improvement Advocacy HealthImprovementAdvocacyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $7,329 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $7,329 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00000 | TotalExpensePct |
Workforce Development WorkforceDevelopmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $22,268 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $22,268 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00000 | TotalExpensePct |
Total Communtity Building Acty TotalCommuntityBuildingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $115,129 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $115,129 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00010 | TotalExpensePct |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bad Debt Expense Reported | 0 | BadDebtExpenseReportedInd |
| Bad Debt Expense | $512,000 | BadDebtExpenseAmt |
| Reimbursed By Medicare | $0 | ReimbursedByMedicareAmt |
| Cost Of Care Reimbursed By Medcr | $455,285 | CostOfCareReimbursedByMedcrAmt |
| Medicare Surplus Or Shortfall | -$455,285 | MedicareSurplusOrShortfallAmt |
Costing Methodology Used CostingMethodologyUsedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cost To Charge Ratio | Yes (X) | CostToChargeRatioInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Written Debt Collection Policy | Yes (1) | WrittenDebtCollectionPolicyInd |
| Financial Assistance Prvsn | Yes (1) | FinancialAssistancePrvsnInd |
| Hospital Facilities | 1 | HospitalFacilitiesCnt |
Hospital Facilities HospitalFacilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 1 | FacilityNum |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ST JUDE CHILDREN'S RESEARCH HOSPITAL | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 262 DANNY THOMAS PLACE | AddressLine1Txt |
| City | MEMPHIS | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 381053678 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Website Address | WWW.STJUDE.ORG | WebsiteAddressTxt |
| State License | TN STATE LICENSE NUMBER 0000000113 | StateLicenseNum |
| Licensed Hospital | Yes (X) | LicensedHospitalInd |
| Childrens Hospital | Yes (X) | ChildrensHospitalInd |
| Research Facility | Yes (X) | ResearchFacilityInd |
Hospital Fclty Policies Prctc HospitalFcltyPoliciesPrctcGrp
Hospital Facility Name HospitalFacilityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ST JUDE CHILDREN'S RESEARCH HOSPITAL | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 1 | FacilityNum |
| First Licensed CY Or PY | 0 | FirstLicensedCYOrPYInd |
| Tax Exempt Hospital CY Or PY | 0 | TaxExemptHospitalCYOrPYInd |
| CHNA Conducted | Yes (1) | CHNAConductedInd |
| Community Definition | Yes (X) | CommunityDefinitionInd |
| Community Demographics | Yes (X) | CommunityDemographicsInd |
| Existing Resources | Yes (X) | ExistingResourcesInd |
| How Data Obtained | Yes (X) | HowDataObtainedInd |
| Community Health Needs | Yes (X) | CommunityHealthNeedsInd |
| Other Health Issues | Yes (X) | OtherHealthIssuesInd |
| Community Hlth Needs Id Process | Yes (X) | CommunityHlthNeedsIdProcessInd |
| Consulting Process | Yes (X) | ConsultingProcessInd |
| Prior CHNA Impact | Yes (X) | PriorCHNAImpactInd |
| CHNA Conducted | 15 | CHNAConductedYr |
| Take Into Account Others Input | Yes (1) | TakeIntoAccountOthersInputInd |
| CHNA Conducted With Other Fclts | 0 | CHNAConductedWithOtherFcltsInd |
| CHNA Conducted With Non Fclts | 0 | CHNAConductedWithNonFcltsInd |
| CHNA Report Widely Available | Yes (1) | CHNAReportWidelyAvailableInd |
| Rpt Available On Own Website | Yes (X) | RptAvailableOnOwnWebsiteInd |
| Own Website URL | SEE PART V, SECTION C | OwnWebsiteURLTxt |
| Paper Copy Public Inspection | Yes (X) | PaperCopyPublicInspectionInd |
| Implementation Strategy Adopt | Yes (1) | ImplementationStrategyAdoptInd |
| Implementation Strategy Adpt | 15 | ImplementationStrategyAdptYr |
| Strategy Posted Website | Yes (1) | StrategyPostedWebsiteInd |
| Strategy Website URL | SEE PART V, SECTION C | StrategyWebsiteURLTxt |
| Organization Incur Excise Tax | 0 | OrganizationIncurExciseTaxInd |
| Elig Criteria Explained | Yes (1) | EligCriteriaExplainedInd |
| Other Criteria | Yes (X) | OtherCriteriaInd |
| Explained Basis | Yes (1) | ExplainedBasisInd |
| App Financial Asst Expln | Yes (1) | AppFinancialAsstExplnInd |
| Other Method | Yes (X) | OtherMethodInd |
| Includes Publicity Measures | Yes (1) | IncludesPublicityMeasuresInd |
| FAP Available On Website | Yes (X) | FAPAvailableOnWebsiteInd |
| FAP Available On Website URL | SEE PART V, SECTION C | FAPAvailableOnWebsiteURLTxt |
| FAP App Available On Website | Yes (X) | FAPAppAvailableOnWebsiteInd |
| FAP App Available On Website URL | SEE PART V, SECTION C | FAPAppAvailableOnWebsiteURLTxt |
| FAP Summary On Website | Yes (X) | FAPSummaryOnWebsiteInd |
| FAP Summary On Website URL | SEE PART V, SECTION C | FAPSummaryOnWebsiteURLTxt |
| FAP Avlbl On Request No Charge | Yes (X) | FAPAvlblOnRequestNoChargeInd |
| FAP App Avlbl On Request No Chrg | Yes (X) | FAPAppAvlblOnRequestNoChrgInd |
| FAP Sum Avlbl On Request No Chrg | Yes (X) | FAPSumAvlblOnRequestNoChrgInd |
| Notified FAP Copy Bill Display | Yes (X) | NotifiedFAPCopyBillDisplayInd |
| Communtity Notified FAP | Yes (X) | CommuntityNotifiedFAPInd |
| FAP Translated | Yes (X) | FAPTranslatedInd |
| FAP Actions On Nonpayment | Yes (1) | FAPActionsOnNonpaymentInd |
| Permit No Actions | Yes (X) | PermitNoActionsInd |
| Collection Activities | 0 | CollectionActivitiesInd |
| Other Actions Taken | Yes (X) | OtherActionsTakenInd |
| Nondis Emergency Care Policy | Yes (1) | NondisEmergencyCarePolicyInd |
| Prospective Medicare Medicaid | Yes (X) | ProspectiveMedicareMedicaidInd |
| Amounts Generally Billed | 0 | AmountsGenerallyBilledInd |
| Gross Charges | 0 | GrossChargesInd |
Supplemental Information SupplementalInformationGrp (10 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL | PART V, SECTION B, LINE 5: ST. JUDE'S 2016 CHNA BUILDS UPON THE 2013 CHNA AND REFLECTS THE ACTIVITIES IDENTIFIED IN ST. JUDE'S 2013 COMMUNITY BENEFIT IMPLEMENTATION PLAN. THE 2016 CHNA WAS LED BY AN INTERNAL TEAM OF ST. JUDE STAFF MEMBERS. THE LEADERSHIP OF THIS TEAM ENGAGED HEALTH RESOURCES IN ACTION (HRIA), A NON-PROFIT PUBLIC HEALTH CONSULTANCY ORGANIZATION, TO CONDUCT THE CHNA. IN AN EFFORT TO DEVELOP A SOCIAL, ECONOMIC, AND HEALTH PORTRAIT OF THE COMMUNITY SERVED BY ST. JUDE FOR THE GREATER MEMPHIS AREA AND NATIONALLY, HRIA REVIEWED EXISTING DATA DRAWN FROM LOCAL, STATE, AND NATIONAL SOURCES. HRIA CONDUCTED QUALITATIVE RESEARCH WITH INTERNAL AND EXTERNAL ST. JUDE STAKEHOLDERS AS WELL AS PATIENTS AND FAMILY MEMBERS SERVED IN ORDER TO SUPPLEMENT QUANTITATIVE FINDINGS WITH PERCEPTIONS OF COMMUNITY STRENGTHS AND ASSETS, THEIR PRIORITY HEALTH CONCERNS, AND SUGGESTIONS FOR FUTURE PROGRAMMING AND SERVICES.FOCUS GROUPS FOCUS GROUPS WERE CONDUCTED WITH CURRENT AND FORMER ST. JUDE PATIENTS, PATIENT CAREGIVERS, AND ST. JUDE CLINICAL, RESEARCH, AND ADMINISTRATIVE STAFF. DIFFERENT TOPIC AREAS WERE EXPLORED BASED ON THE UNIQUE EXPERIENCES OF EACH OF THE GROUPS. THE PATIENT AND CAREGIVER FOCUS GROUPS, CONDUCTED WITH CURRENT PATIENTS AND REPRESENTATIVES OF THE FAMILY ADVISORY AND QUALITY OF LIFE/PALLIATIVE CARE STEERING COUNCILS, EXPLORED THE EXTENT TO WHICH ST. JUDE IS MEETING THE NEEDS OF CHILDREN WITH CATASTROPHIC ILLNESSES AND OPPORTUNITIES TO BRIDGE PATIENT NEEDS IN THE FUTURE. THE CLINICAL, RESEARCH, AND ADMINISTRATIVE STAFF FOCUS GROUP EXPLORED THESE TOPICS AS WELL AS SPECIFIC ISSUES RELATED TO THE GREATER MEMPHIS COMMUNITY. A SEMI-STRUCTURED MODERATOR'S GUIDE WAS USED ACROSS ALL DISCUSSIONS TO ENSURE CONSISTENCY IN THE TOPICS COVERED. WHILE SIMILAR, SEPARATE GUIDES WERE USED FOR THE CAREGIVER AND PATIENT FOCUS GROUPS SO THAT THEY WERE AGE AND DEVELOPMENTALLY APPROPRIATE. EACH FOCUS GROUP WAS FACILITATED BY AN EXPERIENCED HRIA STAFF MEMBER, WHILE A NOTE-TAKER TOOK DETAILED NOTES DURING THE DISCUSSION. ON AVERAGE, FOCUS GROUPS LASTED 30-90 MINUTES. BEFORE THE START OF THE GROUPS, HRIA EXPLAINED THE PURPOSE OF THE STUDY TO PARTICIPANTS AND PARTICIPANTS HAD AN OPPORTUNITY TO ASK QUESTIONS. THEY WERE ALSO NOTIFIED VERBALLY THAT GROUP DISCUSSIONS WOULD REMAIN CONFIDENTIAL, AND NO RESPONSES WOULD BE CONNECTED TO THEM PERSONALLY. PATIENT FOCUS GROUP PARTICIPANTS RECEIVED A $30 GIFT CERTIFICATE AS WELL AS FOOD AND BEVERAGES IN APPRECIATION FOR THEIR TIME. PARTICIPANTS WERE RECRUITED BY ST. JUDE STAFF, WHO ARRANGED ALL LOGISTICS FOR THE ONSITE FOCUS GROUPS.MEDICAL EXECUTIVE COMMITTEE/CLINICAL COUNCIL (INTERNAL) - EMILY BROWNE, DIRECTOR, PROFESSIONAL DEVELOPMENT AND APP - ANDREW M. DAVIDOFF, MD, CHAIR, SURGERY DEPARTMENT - PAM DOTSON, SVP, PATIENT CARE SERVICES/CNO - JANICE ENGLISH, DIRECTOR, NURSING - PATRICIA FLYNN, MD, MEMBER, SVP, MEDICAL DIRECTOR QUALITY AND PATIENT CARE- WILLIAM L. GREENE, PHARM D, CHIEF PHARMACEUTICAL OFFICER - LIZA JOHNSON, MD, STAFF PHYSICIAN, HOSPITALIST - PAT KEEL, SVP, CHIEF FINANCIAL OFFICER - CINDY LEKHY, VP, CLINICAL OPERATIONS - MONIKA METZGER, MD, REGIONAL DIRECTOR, CENTRAL AND SOUTH AMERICA REGIONS, INTERNATIONAL OUTREACH PROGRAM - SEAN PHIPPS, PHD, CHAIR, PSYCHOLOGY DEPARTMENT - ULRIKE REISS, MD, DIRECTOR, CLINICAL HEMATOLOGY DIVISION - GILES W. ROBINSON, MD, ASSISTANT MEMBER, ONCOLOGY DEPARTMENT - VICTOR SANTANA, MD, MEMBER, VP, CLINICAL TRIALS ADMINISTRATION - RON SMITH, VP, SCIENTIFIC OPERATIONS - ELAINE TUOMANEN, MD, CHAIR, DEPARTMENT OF INFECTIOUS DISEASES FAMILY ADVISORY COUNCIL AND QUALITY OF LIFE/PALLIATIVE CARE STEERING COUNCIL (INTERNAL AND EXTERNAL, SOME FAMILY MEMBERS AND FORMER PATIENTS ARE ALSO ST. JUDE EMPLOYEES) - AUDREY DAVIS - DEBBIE HIGGINS - CASEY PAPPAS - GABBY SALINAS - KELLY WADDELL ADOLESCENT PATIENTS, N=4 KEY INFORMANT INTERVIEWS HRIA CONDUCTED INTERVIEWS WITH 16 INDIVIDUALS; 6 WERE INTERNAL TO THE ST. JUDE HOSPITAL AND 10 WERE EXTERNAL REPRESENTATIVES. INTERVIEWEES REPRESENT A RANGE OF SECTORS, INCLUDING LEADERS IN HEALTH CARE AND HEALTH RESEARCH, GOVERNMENT, AND SOCIAL SERVICE ORGANIZATIONS FOCUSING ON VULNERABLE POPULATIONS. SIMILAR TO THE FOCUS GROUPS, A SEMI-STRUCTURED INTERVIEW GUIDE WAS USED ACROSS ALL DISCUSSIONS TO ENSURE CONSISTENCY IN THE TOPICS COVERED. INTERVIEWS WERE APPROXIMATELY 30 MINUTES IN LENGTH. INTERNAL KEY INFORMANT INTERVIEWS - CAROLYN RUSSO, MD, MEDICAL DIRECTOR AFFILIATE PROGRAM - JUSTIN BAKER, CHIEF, DIVISION OF QUALITY OF LIFE AND PALLIATIVE CARE - MARTHA PERINE BEARD, CHAIR, ST. JUDE BOARD OF GOVERNORS- FRAN GREESON, DIRECTOR OF SOCIAL WORK AND JANA KING, DIRECTOR OFDOMICILIARY SERVICES - MICHAEL LINK, MD, CHAIR, ST. JUDE SCIENTIFIC ADVISORY BOARD - ALICIA HUETTEL, DIRECTOR OF FAMILY CENTERED CARE EXTERNAL KEY INFORMANT INTERVIEWS - DR. JOHNATHAN MCCULLERS, CHAIR, DEPARTMENT OF PEDIATRICS, UTHSC/LE BONHEUR CHILDREN'S HOSPITAL - JENNIFER MARSHALL PEPPER, HIV/RYAN WHITE, SHELBY COUNTY - DR. DAVID STERN, DEAN UTHSC COLLEGE OF MEDICINE - DR. BARRY GOLDSPIEL, ACTING CHIEF, PHARMACY DEPARTMENT, CHIEF, CLINICAL PHARMACY SPECIALIST SECTION, NIH - DRS. NADA ELMAGBOUL AND ROBIN WOMEODU, SICKLE CELL DISEASE PROGRAM METHODIST LE BONHEUR HEALTHCARE - VALERIE NAGOSHINER, DEPUTY COMMISSIONER, TN DEPARTMENT OF HEALTH - ANGELA MOORE, PH COORDINATOR, COMMUNITY HEALTH PLANNING, SHELBY COUNTY HEALTH DEPARTMENT - JENNIFER MYRICK, HEALTH SYSTEMS MANAGER, AMERICAN CANCER SOCIETY MID-SOUTH - DEE WIMBERLY, CAROL WEIDENHOFFER, HUGH JONES, SACHARY HIDINGER, ANDREA TUTOR, METHODIST LE BONHEUR HEALTHCARE CHNA TEAM - DR. MARTIN WHITSIDE, TENNESSEE CANCER COALITION |
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL | PART V, SECTION B, LINE 13H: SEE NARRATIVE FOR PART 1, LINE 3C REGARDING THE ORGANIZATION'S FINANCIAL ASSISTANCE POLICY. |
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL | PART V, SECTION B, LINE 15E: SEE NARRATIVE FOR PART 1, LINE 3C REGARDING THE ORGANIZATION'S FINANCIAL ASSISTANCE POLICY. |
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL | PART V, SECTION B, LINE 20E: ST. JUDE DOES NOT TAKE ANY OF THE COLLECTION ACTIONS DESCRIBED IN PART V, SECTION B, LINE 19. |
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL: | PART V, SECTION B, LINE 11: ST. JUDE CHILDREN'S RESEARCH HOSPITALCOMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) IMPLEMENTATION PLAN UPDATE (06/30/17)ST. JUDE: PATIENT POPULATION AND CLINICAL FOCUSTHE COMMUNITY SERVED BY ST. JUDE CAN BEST BE DEFINED BY UNDERSTANDING ST. JUDE'S PATIENT POPULATION AND SCOPE OF CLINICAL SERVICES. ST. JUDE IS A SPECIALTY HOSPITAL THAT TREATS PEDIATRIC CANCER AND BLOOD DISORDERS, AND CHILDREN AND ADOLESCENTS WITH HIV INFECTION. IT SERVES AS A NATIONAL REFERRAL CENTER FOR CHILDREN WITH CANCER AS WELL AS A LOCAL REFERRAL CENTER FOR CHILDREN WITH CANCER, BLOOD DISORDERS, AND HIV/AIDS. ST. JUDE TREATS CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED OR SUSPECTED PEDIATRIC CANCER, HIV INFECTIONS OR CERTAIN HEMATOLOGIC OR GENETIC DISEASES. WE ACCEPT MOST PATIENTS OUTSIDE OUR PRIMARY MARKET BASED ON A REFERRAL FROM THEIR PHYSICIAN OR AN AFFILIATE CLINIC, THEIR AGE, AND THEIR ABILITY TO ENROLL IN AN OPEN CLINICAL TRIAL. IN ADDITION TO BEING TREATED AT ST. JUDE PATIENTS MAY HAVE THE OPTION TO RECEIVE CARE AT ONE OF OUR EIGHT REGIONAL AFFILIATE CLINICS.ST. JUDE'S PRIMARY CLINICAL EFFORT CENTERS ON PROVIDING GROUND-BREAKING, RESEARCH-DRIVEN TREATMENTS FOR CHILDHOOD CANCERS AND OTHER CATASTROPHIC DISEASES IN CHILDREN. MORE SPECIFICALLY, APPROXIMATELY 7,500 PATIENTS ARE SEEN AT ST. JUDE ANNUALLY FOR ACTIVE THERAPY, TREATMENT COMPLETION MONITORING, SURVIVORSHIP SUPPORT OR PARTICIPATION IN RESEARCH PROGRAMS. THE HOSPITAL IS LICENSED FOR 80 INPATIENT BEDS AND CURRENTLY STAFFS 67 BEDS FOR PATIENTS REQUIRING HOSPITALIZATION DURING TREATMENT. IT SHOULD BE NOTED THAT ST. JUDE HAS DEVELOPED UNIQUE RESOURCES THAT ALLOW A SIGNIFICANT PORTION OF PATIENTS TO BE TREATED AS OUTPATIENTS WHO MAY HAVE BEEN ADMITTED AS IN-PATIENTS AT MOST HOSPITALS. THIS IS ACCOMPLISHED THROUGH PATIENT HOUSING DEDICATED SOLELY TO ST. JUDE PATIENT FAMILIES DESIGNED WITH INFECTION CONTROL MEASURES SUCH AS HEPA AIR FILTRATION, INFECTION-RESISTANT SURFACES AND OTHER MEDICAL SAFEGUARDS THAT ARE NOT AVAILABLE IN HOTELS OR PATIENTS' HOMES.THE ST. JUDE AFFILIATE PROGRAM MAKES TREATMENTS DEVELOPED AS CLINICAL TRIALS AT ST. JUDE CHILDREN'S RESEARCH HOSPITAL AVAILABLE TO MORE CHILDREN BY OFFERING MUCH OF THE CARE CLOSE TO HOME. THE ST. JUDE AFFILIATE PROGRAM IS A NETWORK OF PEDIATRIC HEMATOLOGY-ONCOLOGY CLINICS, HOSPITALS, AND IN SOME CASES, UNIVERSITIES UNITED TO EXTEND THE MISSION OF ST. JUDE. THE PHYSICIANS AND STAFF AT THESE SITES WORK IN COLLABORATION WITH THE STAFF OF ST. JUDE TO DELIVER STATE-OF-THE-ART CARE AND INNOVATIVE CLINICAL TRIALS TO CHILDREN WITH CANCER AND BLOOD DISORDERS. ST. JUDE ALSO OPERATES ST. JUDE GLOBAL. ITS MISSION IS TO IMPROVE THE SURVIVAL RATES OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES WORLDWIDE THROUGH THE SHARING OF KNOWLEDGE, TECHNOLOGY AND ORGANIZATIONAL SKILLS. THERE ARE 3 OVERRIDING GOALS:- TO TRAIN THE CLINICAL WORKFORCE THAT WILL BE REQUIRED TO MEET OUR MISSION- TO DEVELOP AND STRENGTHEN HEALTH SYSTEMS AND PATIENT-CENTERED INITIATIVES THAT ENCOMPASS THE ENTIRE CONTINUUM OF CARE REQUIRED FOR CHILDREN WITH CANCER AND NON-MALIGNANT HEMATOLOGICAL DISEASES- TO ADVANCE KNOWLEDGE IN GLOBAL PEDIATRIC ONCOLOGY AND HEMATOLOGY THROUGH RESEARCH TO SUSTAIN A CONTINUOUS IMPROVEMENT IN THE LEVEL AND QUALITY OF CARE DELIVERED AROUND THE GLOBE.ST. JUDE IS A RESEARCH ORGANIZATION, AND THERE ARE TIMES WHEN BASIC RESEARCH DISCOVERIES PERTAIN TO DISEASES THAT ARE BEYOND THE SCOPE OF DISEASES TREATED AS A PRIMARY DIAGNOSIS AT ST. JUDE.FOR THE PURPOSES OF THIS REPORT, THE FOCUS IS SOLELY ON THOSE DISEASES FOR WHICH CHILDREN ARE ADMITTED TO ST. JUDE FOR TREATMENT.CONSISTENT WITH ST. JUDE'S PREVIOUS CHNA, THE FINDINGS IN 2016 HIGHLIGHTED THE ISSUES OF ACCESS TO CARE; CHILDHOOD CANCER; SICKLE CELL DISEASE AND HEMATOLOGY PATIENTS; LIVING WITH HIV AND AIDS; NEEDS OF THE PATIENTS' FAMILIES AND CAREGIVERS; POST TREATMENT AND CARE TRANSITION; HEALTH STATUS OF THE MEMPHIS COMMUNITY AND ADDITIONAL GAPS FOR THE GENERAL PEDIATRIC POPULATION. ST. JUDE HAS CHOSEN TO ADDRESS THESE NEEDS IN THREE GENERAL FOCUS AREAS: IMPROVING ACCESS TO CARE, ENHANCING COORDINATION OF CARE AND IMPROVING CHILD HEALTH STATUS THROUGH HEALTHY LIFESTYLE EDUCATION AND PREVENTION FOR CHILDREN. THESE INITIATIVES, WHICH OFTEN ADDRESS MULTIPLE ISSUES IDENTIFIED IN THE CHNA, WERE CHOSEN BECAUSE THEY ARE ALIGNED WITH OUR MISSION AND OUR CAPABILITIES.AIM #1 IMPROVING ACCESS TO CAREPEDIATRIC HEALTH NEED:ACCESS TO AFFORDABLE HEALTH INSURANCE COVERAGEHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MANAGED CARE DEPARTMENTANTICIPATED OUTCOME:ASSIST UNINSURED PATIENTS WITH ENROLLING IN FUNDING FOR WHICH THEY QUALIFYACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. RENEW CONTRACT WITH VENDOR TO PROVIDE CERTIFIED APPLICATION COUNSELOR SERVICES TO ASSIST PATIENT FAMILIES APPLYING FOR HEALTH INSURANCE COVERAGE THROUGH THE FEDERALLY-FACILITATED MARKETPLACE.2. CONDUCT AN AUDIT OF THE SCREENING PROCESS TO VALIDATE COMPLIANCE. MAKE PROCESS ADJUSTMENTS AS NEEDED.SELECTED ACCOMPLISHMENTS:- THE AGREEMENT WITH FIRSTSOURCE SOLUTIONS USA, LLC DBA MEDASSIST IS RENEWED ANNUALLY. MEDASSIST IS THE VENDOR USED TO PROVIDE CERTIFIED APPLICATION COUNSELOR SERVICES TO UNINSURED PATIENTS. - AN AUDIT OF THE SCREENING PROCESS HAS BEEN DEVELOPED AND WILL CONTINUE TO BE CONDUCTED ON A MONTHLY BASIS TO ENSURE THAT ALL FAMILIES ARE GIVEN ASSISTANCE WITH THE SCREENING AND ENROLLMENT PROCESS. IN FY17, 95% OF UNINSURED PATIENTS WERE OFFERED ASSISTANCE AND FIFTY UNINSURED PATIENTS WERE ENROLLED IN HEALTH PLANS. THE REMAINING 5% WERE NOT CONTACTED BECAUSE THEY WERE IN THE AFTER COMPLETION OF THERAPY PROGRAM AND WERE NOT HERE LONG.PEDIATRIC HEALTH NEED:PALLIATIVE CAREHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, DEPARTMENT OF ONCOLOGY, DIVISION OF QUALITY OF LIFE AND PALLIATIVE CAREANTICIPATED OUTCOME:INCREASE THE NUMBER OF CLINICIANS TRAINED IN PALLIATIVE CARE MEDICINE (PCM) AND EDUCATIONAL OPPORTUNITIES FOR PCMACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. RECRUIT AND TRAIN TWO PHYSICIAN FELLOWS IN THE PALLIATIVE CARE TRAINING PROGRAM.2. PROVIDE TRAINING IN PALLIATIVE CARE FOR ADVANCED PRACTICE HEALTHCARE PERSONNEL THROUGH TARGETED CONFERENCES AND OTHER EDUCATIONAL OPPORTUNITIES INCLUDING END-OF-LIFE NURSING EDUCATION CONSORTIUM (ELNEC) CONFERENCE, AN INSTITUTION-DEVELOPED QUALITY OF LIFE SEMINAR (QOLA), AND A 2 DAY PEDIATRIC ONCOLOGY PALLIATIVE CARE CONFERENCE.3. EDUCATE COMMUNITY PROVIDERS ABOUT PCM THROUGH COMMUNITY-BASED BRIDGING PROGRAMS FOR HOME HEALTH AND HOSPICE CARE THROUGH THE QUALITY OF LIFE FOR ALL KIDS PROGRAM VIA A THREE HOUR DIDACTIC CURRICULUM.4. ENHANCE TRAINING OPPORTUNITIES WITH ST. JUDE AFFILIATES.SELECTED ACCOMPLISHMENTS:- EACH YEAR THE PALLIATIVE CARE TRAINING PROGRAM HAS BEEN SUCCESSFUL IN RECRUITING AND TRAINING TWO PHYSICIAN FELLOWS.- ENROLLMENT: FY16 FY17ELNEC 32 78QOLA 37 29NEW PEDIATRIC ONCOLOGY PALLIATIVE CARE CONFERENCE 325IN ADDITION, ALL BEDSIDE NURSES ARE REQUIRED TO COMPLETE ELNEC WITHIN THREE YEARS. ALSO, INPATIENT AND OUTPATIENT NURSES ARE REQUIRED AND SUPPORTED TO COMPLETE BOTH SEMINARS (A TOTAL OF 24.5 CEUS IN PCM). - COMMUNITY PROVIDER EDUCATION HAPPENS TWICE A MONTH THROUGH ST. JUDE'S COMBINED FELLOWSHIP PROGRAM BOARD REVIEW SERIES. EACH SESSION AVERAGES 10 ATTENDEES RANGING FROM GRADUATE STUDENTS TO MEDICAL STUDENTS TO ADVANCED CLINICIANS.- THE SJ AFFILIATE STAFF ARE INVITED TO PARTICIPATE IN ELNEC, THE QOL SEMINAR AND THE PEDIATRIC PALLIATIVE ONCOLOGY SYMPOSIUM AT NO COST, AND ARE INCLUDED IN THE NUMBERS CITED ABOVE.PEDIATRIC HEALTH NEED:HEALTHCARE OF CHILDHOOD CANCER SURVIVORSHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, DEPARTMENT OF ONCOLOGY, DIVISION OF CANCER SURVIVORSHIPANTICIPATED OUTCOME:PROVIDE CANCER SURVIVORSHIP INFORMATION TO BOTH CAREGIVERS AND SURVIVORS VIA SURVIVORS' DAY CONFERENCE AND ST. JUDE LIFEACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. PROVIDE WORKSHOPS AND SPEAKERS THAT OFFER INFORMATION ABOUT AVAILABLE RESOURCES.2. GIVE SURVIVORS AND THEIR FAMILIES THE OPPORTUNITY TO LEARN FROM OTHER SURVIVORS.3. ENSURE THAT SURVIVORS UNDERSTAND HOW TO APPROACH HEALTHCARE POST-TREATMENT.4. OFFER AN ONLINE RESOURCE FOLLOWING THE CONFERENCE FOR CONTINUOUSFLOW OF SURVIVORSHIP INFORMATION.5. ASSESS LATE EFFECTS OF CANCER THERAPY ON PEDIATRIC CANCER SURVIVORS.6. USE INFORMATION FROM THESE STUDIES TO DEFINE RISK GROUPS FOR VARIOUS LATE EFFECTS AND ASSESS INTERVENTIONS. |
| SELECTED ACCOMPLISHMENTS: | LECTURES/WORKSHOPS PROVIDED BY MELISSA M. HUDSON:- 17TH ANNUAL ONCOLOGY SYMPOSIUM, AVERA CANCER INSTITUTE, "THE MYRIAD OF LATE AND LONG-TERM HEALTH RISKS OF CANCER SURVIVORS AND "CANCER SURVIVORSHIP CARE MODELS", SIOUX FALLS, SOUTH DAKOTA, SEPTEMBER 29-30, 2016- CANCER SURVIVORSHIP: OPTIMIZING CARE AND OUTCOMES, MICHAEL GARIL ENDOWED LECTURESHIP ON LATE EFFECTS: "CHILDHOOD SURVIVORSHIP COHORT RESEARCH: LESSONS LEARNED AND FUTURE DIRECTIONS", DANA FARBER CANCER INSTITUTE, BOSTON, MA, NOVEMBER 17-18, 2016- PFIZER, INC. U.S. GENOTROPIN ADVISORY BOARD MEETING, "SAFETY OF GROWTH HORMONE THERAPY IN CHILDHOOD CANCER SURVIVORS", NEW YORK, NEW YORK, DECEMBER 9, 2016- RONALD MCDONALD BOARD MEETING, SURVIVORSHIP RESEARCH AT ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TENNESSEE, JANUARY 17, 2017- PRIMARY CARE SYMPOSIUM - CANCER SURVIVORSHIP: A PRIMARY CARE AND ONCOLOGY COLLABORATION, "PRIMARY CARE OF SURVIVORS OF CHILDHOOD, ADOLESCENT AND YOUNG ADULT CANCERS" WEST CANCER CENTER, MEMPHIS, TENNESSEE, MARCH 7, 2017 TRANSLATIONAL CANCER RESEARCH SEMINAR SERIES, CINCINNATI CHILDREN'S HOSPITAL, "PEDIATRIC SURVIVORSHIP CARE IN THE 21ST CENTURY: EVOLVING AND EMERGING HEALTH RISKS", CINCINNATI, OHIO, APRIL 6, 2017- CANCER SURVIVORSHIP RESEARCH AND BEST PRACTICES CONFERENCE: CHANGING LIVES THROUGH QUALITY SURVIVORSHIP CARE, "OPTIMIZING HEALTH AND HEALTH CARE TRANSITIONS IN CHILDHOOD CANCER SURVIVORS", CINCINNATI, OHIO, APRIL 7, 2017- ANNA T. MEADOWS LECTURE IN PEDIATRIC CANCER SURVIVORSHIP, "THE ROLE OF SURVIVORSHIP RESEARCH IN ADVANCING CHILDHOOD CANCER CARE AND QUALITY OF SURVIVAL", THE CENTER FOR CHILDHOOD CANCER RESEARCH (CCCR) AT THE CHILDREN'S HOSPITAL OF PHILADELPHIA, PHILADELPHIA, PENNSYLVANIA, APRIL 25, 2017LECTURES/WORKSHOPS PROVIDED BY DANIEL MULROONEY:- PEDIATRIC ONCOLOGY ISSUES, THE CHILDREN'S HOSPITAL AT SAINT FRANCIS, TULSA, OK, SEPTEMBER 30, 2016 - IMPLEMENTATION OF COG GUIDELINES FOR SURVIVORSHIP, THE CHILDREN'S HOSPITAL AT SAINT FRANCIS, TULSA, OK, SEPTEMBER 2016 - UPDATES IN FERTILITY OUTCOMES IN PEDIATRIC CANCER SURVIVORS, THE ONCOFERTILITY CONSORTIUM, PRENTICE WOMEN'S HOSPITAL, NORTHWESTERN UNIVERSITY, CHICAGO, IL, NOVEMBER 2, 2016 - THE SPECTRUM OF CARDIOVASCULAR DISEASE AFTER CHILDHOOD CANCER THERAPY, GREEHEY CHILDREN'S CANCER RESEARCH INSTITUTE SEMINAR SERIES, SAN ANTONIO, TX, JUNE 2, 2017 - FERTILITY PRESERVATION AT ST. JUDE: PAST, PRESENT, AND FUTURE, GRAND ROUNDS, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN, SEPTEMBER 8, 2016 - OPTIMIZING CARE FOR THE SURVIVOR OF CHILDHOOD CANCER, AFFILIATE PHYSICIANS' CONFERENCE, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN, APRIL 7, 2017LECTURES/WORKSHOPS PROVIDED BY MATTHEW EHRHARDT:- LATE EFFECTS OF CHILDHOOD CANCER: THE COST OF CURE. PEDIATRIC ONCOLOGY EDUCATION (POE) PROGRAM, LUNCH AND LEARN SERIES, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN, JULY 2016- PEDIATRIC CANCER SURVIVORSHIP: MODELS OF CARE AND SURVEILLANCE GUIDELINES, CHINA VISITING SCHOLAR PROGRAM, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN, JULY 2016- CHILDREN'S ONCOLOGY GROUP LONG-TERM FOLLOW-UP GUIDELINES FOR SURVIVORS OF CHILDHOOD, ADOLESCENT, AND YOUNG ADULT CANCERS. ADVANCING CARDIOVASCULAR CARE OF THE ONCOLOGY PATIENT, AMERICAN COLLEGE OF CARDIOLOGY, WASHINGTON, D.C., FEBRUARY 2017- EXERCISE BEFORE, DURING, AND AFTER THERAPY: HOW MUCH SHOULD THE CANCER PATIENT DO? ADVANCING CARDIOVASCULAR CARE OF THE ONCOLOGY PATIENT, AMERICAN COLLEGE OF CARDIOLOGY, WASHINGTON, D.C., FEBRUARY 2017- TAKING THE CUE: ELEMENTS OF A WELL-CHAMPIONED SURVIVORSHIP PROGRAM. ADVANCING CARDIOVASCULAR CARE OF THE ONCOLOGY PATIENT, AMERICAN COLLEGE OF C ARDIOLOGY, WASHINGTON, D.C., FEBRUARY 2017- HOW TO MITIGATE CARDIOTOXICITY: STATINS AND PROTON THERAPY FOR ALL CHILDHOOD AND ADULT CANCER PATIENTS AND SURVIVORS? ADVANCING CARDIOVASCULAR CARE OF THE ONCOLOGY PATIENT, AMERICAN COLLEGE OF CARDIOLOGY, WASHINGTON, D.C., FEBRUARY 2017- SURVIVING CHILDHOOD CANCER. ST. JUDE MIDWEST AFFILIATE PEDIATRIC CANCER SURVIVORSHIP CONFERENCE, PEORIA, IL, APRIL 2017- CANCER SURVIVORSHIP AND THE AFTER COMPLETION OF THERAPY CLINIC. ST. JUDE MIDWEST AFFILIATE ASSOCIATION OF PEDIATRIC HEMATOLOGY/ONCOLOGY NURSES (APHON), PEORIA, IL, APRIL 2017OPPORTUNITIES FOR SURVIVORS TO LEARN FROM EACH OTHER:- ST. JUDE HOSTS PERIODIC CELEBRATIONS OF SURVIVORSHIP ATTENDED BY SURVIVORS, FAMILIES AND FRIENDS. THE EVENT PROVIDES A FORUM TO CELEBRATE SURVIVORSHIP, EDUCATE ATTENDEES ABOUT HEALTH EFFECTS OF CHILDHOOD CANCER AND RESEARCH PROGRESS IN THIS AREA, AND SHARE INFORMATION ABOUT HEALTH RESOURCES. - ST. JUDE SURVIVOR DAY ACTIVITIES, SEPTEMBER 10, 2016: OVERVIEW OF PROGRESS IN PEDIATRIC CANCER TREATMENT BY DR. JAMES DOWNING. HEALTH FAIR WITH BOOTHS FEATURING HEALTH PROMOTION MATERIALS FROM HOSPITAL SERVICE AREAS.- PLANNED ACTIVITIES FOR 2017 ST. JUDE SURVIVOR DAY (SCHEDULED FOR SEPTEMBER 9, 2017): INSPIRATIONAL CANCER SURVIVOR DR. WENDY HARPHAM WILL SHARE HER SURVIVORSHIP EXPERIENCES IN KEYNOTE ADDRESS ENTITLED "HAPPINESS IN A STORM". SURVIVORSHIP STAFF AND DR. HARPHAM WILL LEAD WORKSHOPS FOCUSING ON HOPE AND RESILIENCY IN OVERCOMING THE OBSTACLES ASSOCIATED WITH THE CANCER EXPERIENCE AND ITS AFTERMATH.ENSURING THAT SURVIVORS UNDERSTAND HOW TO APPROACH HEALTHCARE POST-TREATMENT:- SURVIVORS AND THEIR FAMILIES ATTENDING THE AFTER COMPLETION OF THERAPY AND ST. JUDE LIFETIME COHORT CLINICS ROUTINELY RECEIVE COUNSELING ABOUT THEIR HEALTH HISTORY, CANCER-RELATED HEALTH RISKS, HEALTH SCREENING RECOMMENDED FOR THEIR SPECIFIC CANCER TREATMENT EXPOSURES, AND METHODS OF RISK REDUCTION. A SURVIVORSHIP CARE PLAN IS PROVIDED AT THE FIRST EVALUATION THAT DETAILS THE CANCER DIAGNOSIS, TREATMENT, MAJOR HEALTH EVENTS THAT HAVE OCCURRED DURING AND AFTER THERAPY, CANCER-RELATED HEALTH RISKS, AND RECOMMENDED HEALTH SCREENING. THE SURVIVORSHIP CARE PLAN IS UPDATED AFTER EVERY HEALTH EVALUATION. - FOR SURVIVORS WHO DO NOT WISH TO PARTICIPATE IN THE ACT OR ST. JUDE LIFETIME COHORT PROGRAMS, THESE SAME SERVICES ARE AVAILABLE THROUGH THE ST. JUDE ALUMNUS PROGRAM OFFICE.- RELATED TO A+ TRANSITION TASK FORCE ACTIVITIES, SURVIVORSHIP STAFF HAVE BEEN INVOLVED IN MULTIDISCIPLINARY EFFORTS TO INTRODUCE AND CONSISTENTLY ADDRESS SURVIVORSHIP TRANSITION ISSUES, PARTICULARLY PSYCHOSOCIAL AND REHABILITATION NEEDS, AT EARLIER TIME POINTS AFTER DIAGNOSIS. ONLINE RESOURCES:- PERIODIC BRIEF PUBLICATIONS FEATURE SURVIVOR STORIES AND EDUCATIONAL TOPICS:LONG-TERM FOLLOW-UP NEWSLETTERS AND BRIEFS (AVAILABLE AT HTTPS://LTFU.STJUDE.ORG/) ARE PUBLISHED ON A QUARTERLY BASIS.LIFELINE NEWSLETTERS (AVAILABLE AT HTTPS://WWW.STJUDE.ORG/TREATMENT/SURVIVORSHIP/PARTICIPATE-IN-ST-JUDE-LIFE-STUDY/LIFELINE-NEWSLETTER.HTML) ARE PUBLISHED SEMIANNUALLY.- OTHER SURVIVORSHIP RESOURCES ARE AVAILABLE AT: HTTPS://WWW.STJUDE.ORG/TREATMENT/SURVIVORSHIP/PARTICIPATE-IN-ST-JUDE-LIFE-STUDY/HANDOUTS.HTMLASSESSING LATE EFFECTS OF CANCER THERAPY ON PEDIATRIC CANCER SURVIVORS:- THE AFTER COMPLETION OF THERAPY AND ST. JUDE LIFETIME COHORT CLINICS CONTINUE TO EVALUATE MORE THAN 2000 LONG-TERM (5+ YEAR) SURVIVORS ON AN ANNUAL BASIS FOR COMPLICATIONS RELATED TO THEIR CANCER OR ITS TREATMENT.USING THE INFORMATION TO DEFINE RISK GROUPS FOR VARIOUS LATE EFFECTS AND ASSESS INTERVENTIONS:- ST. JUDE INVESTIGATORS HAVE PUBLISHED SEMINAL RESEARCH CHARACTERIZING TREATMENT-RELATED CARDIOVASCULAR, PULMONARY, ENDOCRINE, NEUROLOGIC, NEUROSENSORY, NEUROCOGNITIVE, AND PSYCHOSOCIAL OUTCOMES AMONG LONG-TERM SURVIVORS THAT HAS BEEN USED TO IDENTIFY SURVIVORS AT HIGH RISK FOR MORBIDITY WHO MAY BE TARGETED FOR PREVENTIVE/REMEDIAL INTERVENTIONS.WILSON CL, CHEMAITILLY W, JONES KE, KASTE SC, SRIVASTAVA DK, OJHA RP, YASUI Y, PUI CH, ROBISON LL, HUDSON MM, NESS KK. MODIFIABLE FACTORS ASSOCIATED WITH AGING PHENOTYPES AMONG ADULT SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA. J CLIN ONCOL. 2016; 34(21):2509-15.BOLAND AM, GIBSON TM, LU L, KASTE SC, DELANY JP, PARTIN RE, LANCTOT JQ, HOWELL CR, NELSON HH, CHEMAITILLY W, PUI CH, ROBISON LL, MULROONEY DA, HUDSON MM, NESS KK. DIETARY PROTEIN INTAKE AND LEAN MASS IN SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT FROM THE ST. JUDE LIFETIME COHORT STUDY. PHYS THER. 2016; 96(7): 1029-38.KRULL KR, CHEUNG YT, LIU W, FELLAH S, REDDICK WE, BRINKMAN TM, KIMBERG C, OGG R, SRIVASTAVA DK, PUI CH, ROBISON LL, HUDSON MM. CHEMOTHERAPY PHARMACODYNAMICS, NEUROIMAGING AND NEUROCOGNITIVE OUTCOMES IN LONG-TERM SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA. J CLIN ONCOL. 2016; 34(22):2644-53.MOGIL RJ, KASTE SC, FERRY RJ, HUDSON MM, HOWELL CR, PARTIN RE, SRIVASTAVA DK, ROBISON LL, NESS KK. EFFECT OF LOW-MAGNITUDE, HIGH-FREQUENCY MECHANICAL STIMULATION ON BMD AMONG YOUNG CHILDHOOD CANCER SURVIVORS: A RANDOMIZED CLINICAL TRIAL. JAMA ONCOL. 2016; 2(7): 908-14. |
| EHRHARDT MJ, BHAKTA N, LIU Q, YASUI Y, KRASIN MJ, MULROONEY DA, HUDSON | MM, ROBISON LL. ABSENCE OF BASAL CELL CARCINOMA IN IRRADIATED CHILDHOOD CANCER SURVIVORS OF BLACK RACE: A REPORT FROM THE ST. JUDE LIFETIME COHORT STUDY. CANCER EPIDEMIOL BIOMARKERS PREV. 2016; 25(9):1356-60.FERNANDEZ-PINEDA I, HUDSON MM, PAPPO AS, BISHOP MW, KLOSKY JL, BRINKMAN TM, SRIVASTAVA DK, NEEL MD, RAO BN, DAVIDOFF AM, KRULL KR, ROBISON LL, NESS KK. LONG-TERM FUNCTIONAL OUTCOMES AND QUALITY OF LIFE IN ADULT SURVIVORS OF CHILDHOOD EXTREMITY SARCOMAS: A REPORT FROM THE ST. JUDE LIFETIME COHORT STUDY. J CANCER SURVIV. 2017;11(1):1-12.GREEN DM, ZHU L, WANG M, NESS KK, KRASIN MJ, BHAKTA NH, MCCARVILLE MB, SRINIVASAN S, STOKES DC, SRIVASTAVA D, OJHA R, SHELTON K, PUI CH, ARMSTRONG GT, MULROONEY DA, METZGER M, SPUNT SL, NAVID F, DAVIDOFF AM, RAO BN, ROBISON LL, HUDSON MM. PULMONARY FUNCTION AFTER TREATMENT FOR CHILDHOOD CANCER: A REPORT FROM THE ST. JUDE LIFETIME COHORT STUDY (SJLIFE). ANN AM THORAC SOC. 2016; 13(9):1575-85.CHEUNG YT, EDELMANN MN, MULROONEY DA, GREEN DM, CHEMAITILLY W, JOHN N, ROBISON LL, HUDSON MM, KRULL KR. URIC ACID AND NEUROCOGNITIVE FUNCTION IN SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CHEMOTHERAPY ONLY. CANCER EPIDEMIOL BIOMARKERS PREV. 2016; 25(8):1259-67.CHEUNG YT, SABIN ND, REDDICK WE, BHOJWANI D, LIU W, BRINKMAN TM, GLASS JO, HWANG SN, SRIVASTAVA D, PUI CH, ROBISON LL, HUDSON MM, KRULL KR. LEUKOENCEPHALOPATHY AND LONG-TERM NEUROBEHAVIORAL, NEUROCOGNITIVE AND BRAIN IMAGING OUTCOMES IN SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CHEMOTHERAPY: A LONGITUDINAL ANALYSIS. LANCET HAEMATOL. 2016;3(10):E456-E466.ZHANG FF, OJHA RP, KRULL KR, GIBSON TM, LU L, LANCTOT J, CHEMAITILLY W, ROBISON LL, HUDSON MM. ADULT SURVIVORS OF CHILDHOOD CANCER HAVE POOR ADHERENCE TO DIETARY GUIDELINES. J NUTR. 2016;146(12):2497-2505.EHRHARDT MJ, SANDLUND JT, ZHANG N, LIU W, NESS KK, BHAKTA N, CHEMAITILLY W, KRULL KR, BRINKMAN TM, CROM DB, KUN L, KASTE SC, ARMSTRONG GT, GREEN DM, SRIVASTAVA K, ROBISON LL, HUDSON MM, MULROONEY DA. LATE OUTCOMES OF ADULT SURVIVORS OF CHILDHOOD NON-HODGKIN LYMPHOMA: A REPORT FROM THE ST. JUD LIFETIME COHORT STUDY. PEDIATR BLOOD CANCER. 2017 JUN;64(6).CHEUNG YT, CHEMAITILLY W, MULROONEY DA, BRINKMAN TM, LIU W, BANERJEE P, SRIVASTAVA D, PUI CH, ROBISON LL, HUDSON MM, KRULL KR. ASSOCIATION BETWEEN DEHYDROEPIANDROSTERONE-SULFATE AND ATTENTION IN LONG-TERM SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH ONLY CHEMOTHERAPY. PSYCHONEUROENDOCRINOLOGY. 2017;76:114-118.WILLARD VW, KLOSKY JL, LI C, SRIVASTAVA DK, BRINKMAN TM, ROBISON LL, HUDSON MM, PHIPPS S. THE IMPACT OF CHILDHOOD CANCER: PERCEPTIONS OF ADULT SURVIVORS. CANCER. 2017 MAY 1;123(9):1625-1634.HUDSON MM, EHRHARDT MJ, BHAKTA N, BAASSIRI M, EISSA H, CHEMAITILLY W, GREEN DM, MULROONEY DA, ARMSTRONG GT, BRINKMAN TM, KLOSKY JL, KRULL KR, SABIN ND, WILSON CL, HUANG IC, BASS JK, HALE K, KASTE S, KHAN RB, SRIVASTAVA DK, YASUI Y, JOSHI VM, SRINIVASAN S, STOKES D, HOEHN ME, WILSON M, NESS KK, ROBISON LL. APPROACH FOR CLASSIFICATION AND SEVERITY-GRADING OF LONG-TERM AND LATE-ONSET HEALTH EVENTS AMONG CHILDHOOD CANCER SURVIVORS IN THE ST. JUDE LIFETIME COHORT. CANCER EPIDEMIOL BIOMARKERS PREV. 2017 MAY;26(5):666-674.JIN J, ZHU L, TONG X, NESS KK. T-TYPE CORRECTED-LOSS ESTIMATION FOR ERROR-IN-VARIABLE MODEL. COMMUN STAT THEORY METHODS. 2017;46(2):616-627.CHEMAITILLY W, LI Z, KRASIN MJ, BROOKE RJ, WILSON CL, GREEN DM, KLOSKY JL, BARNES N, CLARK KL, FARR JB, FERNANDEZ-PINEDA I, BISHOP MW, METZGER M, PUI CH, KASTE SC, NESS KK, SRIVASTAVA DK, ROBISON LL, HUDSON MM, YASUI Y, SKLAR CA. PREMATURE OVARIAN INSUFFICIENCY IN CHILDHOOD CANCER SURVIVORS: A REPORT FROM THE ST. JUDE LIFETIME COHORT. J CLIN ENDOCRINOL METAB. MARCH 24, 2017. EPUB AHEAD OF PRINT.GREEN DM, ZHU L, WANG M, CHEMAITILLY W, SRIVASTAVA D, KUTTEH WH, KE RW, RIBEIRO RC, ROBISON LL, HUDSON MM. EFFECT OF CRANIAL IRRADIATION ON SPERM CONCENTRATION OF ADULT SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA. A REPORT FROM THE ST. JUDE LIFETIME COHORT STUDY. HUM REPROD. 2017 JUN 1;32(6):1192-1201.VUOTTO SC, OJHA RP, LI C, KIMBERG C, KLOSKY JL, KRULL KR, SRIVASTAVA DK, ROBISON LL, HUDSON MM, BRINKMAN TM. THE ROLE OF BODY IMAGE DISSATISFACTION IN THE ASSOCIATION BETWEEN TREATMENT-RELATED SCARRING OR DISFIGUREMENT AND PSYCHOLOGICAL DISTRESS IN ADULT SURVIVORS OF CHILDHOOD CANCER. PSYCHOONCOLOGY. 2017 APR 18. EPUB AHEAD OF PRINT.PEDIATRIC HEALTH NEED:COMMUNITY EDUCATIONHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, COMMUNICATIONS & PUBLIC RELATIONS DEPARTMENTANTICIPATED OUTCOME:PROVIDE INFORMATION AND EDUCATION ABOUT HEALTHCARE RESOURCES AND HEALTHCARE CAREERSACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. ST. JUDE PROFESSIONALS WILL PROVIDE INFORMATION AND RESOURCES ABOUT SICKLE CELL DISEASE, HIV, CANCER, FLU, AND OTHER PEDIATRIC LIFE-THREATENING DISEASES.2. INVENTORY EDUCATIONAL OPPORTUNITIES ABOUT HEALTHCARE CAREERS ALREADY AVAILABLE FROM ST. JUDE TO DETERMINE AREAS OF FOCUS.SELECTED ACCOMPLISHMENTS:ST. JUDE PROFESSIONALS PROVIDING INFORMATION AND RESOURCES:- OFFERED RADIO STATION PRODUCERS ST. JUDE PROFESSIONALS WHO CAN PROVIDE LISTENERS WITH DETAILS ABOUT COMMUNITY RESOURCES AVAILABLE FOR LEARNING ABOUT AND BEING TESTED FOR DISORDERS/DISEASES SUCH AS SICKLE CELL TRAIT AND HIV- SICKLE CELL DISEASE - YVONNE CARROLL, LET'S TALK ABOUT IT WITH BOBBIE THOMPSON (PROGRAM NAME), LOK 8/30/16: HTTP://WWW.WLOK.COM/- IN ADDITION, ST. JUDE CONDUCTED MORE THAN 75 30-SECOND EDUCATIONAL SPOTS SEPTEMBER THROUGH DECEMBER 2016. TOPICS INCLUDED: HIV VOICES PROJECT, AIDS SUPPORT, SICKLE CELL STEP, BLOOD DONOR CENTER, CANCER EDUCATION, ST. JUDE SCIENCE AMBASSADORS AND SCIENCE SOUND BITES. AN HPV VACCINATION SPOT IS IN DEVELOPMENT.- "PROMISE" MAGAZINE IS ONE VEHICLE USED BY THE ST. JUDE COMMUNICATIONS AND PUBLIC RELATIONS DEPARTMENT TO EDUCATE THE PUBLIC ABOUT SICKLE CELL DISEASE, HIV, CANCER AND OTHER DISEASES. "PROMISE" IS MAILED TO BETWEEN 200,000 AND 300,000 READERS, WHICH INCLUDE DONORS, EMPLOYEES, PEER INSTITUTIONS, CEOS OF FORTUNE 500 COMPANIES, SELECT MEDIA AND INDIVIDUALS WHO SUBSCRIBE THROUGH OUR ONLINE SUBSCRIPTION FORM. ALL THE ARTICLES APPEAR ONLINE, WHERE THEY HAVE AN EVEN WIDER READERSHIP. AN E-NEWSLETTER VERSION OF "PROMISE" IS ALSO SENT TO NEARLY 10,000 SUBSCRIBERS.A FEW OF THE EDUCATIONAL ARTICLES IN THIS MAGAZINE HAVE INCLUDED: THE SUMMER 2016 "PROMISE" INCLUDED A STORY ON HOW ST. JUDE IS WORKING TO MAKE THE FLU VACCINE MORE EFFECTIVE, AND HOW NUTRITIONAL DEFICITS OF VITAMINS A AND D, ESPECIALLY PREVALENT IN THE MEMPHIS AREA, HAMPER THE VACCINE'S EFFICACY.HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/STORIES/PROMISE-MAGAZINE/SUMMER-2016/FIGHTING-FLU-WITH-A-VITAMIN-BOOST.HTMLIN THE SAME ISSUE, WE SPOTLIGHTED A GROUP OF LOCAL YOUTH WHO MEET MONTHLY TO HELP CLINICIANS AND SCIENTISTS NATIONWIDE IMPROVE THE RESEARCH AND TREATMENT OF HIV/AIDS.HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/STORIES/PROMISE-MAGAZINE/SUMMER-2016/A-SEAT-AT-THE-TABLE-YOUTH-HELP-HIV-AIDS-RESEARCHERS.HTML THE AUTUMN 2016 ISSUE OF "PROMISE" EXPLAINED HOW ST. JUDE RESEARCHERS ENSURE CODEINE IS GIVEN ONLY TO CHILDREN WITH SICKLE CELL DISEASE WHOSE GENES INDICATE IT'S SAFE AND EFFECTIVE.HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/STORIES/PROMISE-MAGAZINE/AUTUMN-2016/WHEN-GENES-POINT-TO-THE-RIGHT-MEDICINE.HTML THE SPRING 2017 ISSUE OF "PROMISE" ALSO HIGHLIGHTED A FREE APP THAT PEOPLE CAN DOWNLOAD TO SCAN PICTURES OF THEIR CHILDREN FOR RETINOBLASTOMA, A COMMON CHILDHOOD EYE CANCER.HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/STORIES/PROMISE-MAGAZINE/SPRING-2017/SAVING-EYES-AND-LIVES-WORLDWIDE.HTML- ST. JUDE HAS A PRESENCE ON SOCIAL MEDIA AS @STJUDERESEARCH ACROSS EIGHT PLATFORMS WITH A TOTAL OF ALMOST 35,000 FOLLOWERS. THE GOAL FOR SOCIAL MEDIA IS TO INCREASE THE RECOGNITION AND UNDERSTANDING OF ST. JUDE SCIENCE, MEDICINE AND TRANSLATIONAL RESEARCH BY HIGHLIGHTING SCIENTIFIC AND MEDICAL STUDIES, SUCCESSES, PROJECTS AND PROGRAMS. THE PLATFORMS ALSO FEATURE CAREER OPPORTUNITIES FOR RESEARCH AND CLINICAL CARE STAFF. THE AUDIENCE IS CURRENT AND POTENTIAL PHYSICIANS, SCIENTISTS, CLINICIANS, POSTDOCS, REFERRING PHYSICIANS, PATIENTS AND THEIR FAMILIES. WITHIN THE LAST YEAR, FEATURED TOPICS HAVE RANGED FROM CHILDHOOD CANCER FACTS TO PALLIATIVE CARE AWARENESS TO OPENINGS FOR SPECIALTY CANCER CLINICS. |
| EDUCATIONAL OPPORTUNITIES ABOUT HEALTHCARE CAREERS: | - THE SUMMER 2016 EDITION OF PROMISE INCLUDED INFORMATION ABOUT THE ST. JUDE GRADUATE SCHOOL OF BIOMEDICAL SCIENCES, THE FIRST DEGREE-GRANTING PROGRAM EVER ESTABLISHED ON THE CAMPUS OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL.HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/STORIES/PROMISE-MAGAZINE/SUMMER-2016/NEXT-GENERATION-EDUCATION-THE-ST-JUDE-GRADUATE-SCHOOL.HTML- THE SPRING 2017 ISSUE OF PROMISE SHOWED HOW ST. JUDE DISPELS COMMON HEALTH CARE MYTHS FOR LOCAL SCHOOL CHILDREN AND MAKES SCIENCE COME TO LIFE FOR STUDENTS AND TEACHERS IN LOCAL CLASSROOMS. HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/STORIES/PROMISE-MAGAZINE/SPRING-2017/BRINGING-SCIENCE-INTO-THE-CLASSROOM.HTML- APPROXIMATELY 150 LOCAL HIGH SCHOOL STUDENTS AND TEACHERS VISITED ST. JUDE IN MARCH 2017 FOR THE SECOND ANNUAL SCIENCE SCHOLARS OF TOMORROW SYMPOSIUM. THE DAY-LONG EVENT FEATURED SCIENTIFIC PRESENTATIONS AND TOURS OF LABORATORIES, CLINICS AND CORE FACILITIES, ENABLING STUDENTS TO INTERACT WITH SCIENTISTS AND CLINICIANS.PEDIATRIC HEALTH NEED:ST. JUDE AFFILIATE NETWORKHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, AFFILIATE PROGRAM OFFICEANTICIPATED OUTCOME:THE ST. JUDE AFFILIATE NETWORK SHOULD BE MAINTAINED TO EXPAND OPPORTUNITIES FOR SERVICES TO A LARGER NUMBER OF CHILDREN.ACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. EVALUATE OPPORTUNITIES TO EXPAND TO ADDITIONAL LOCATIONS.2. ENHANCE OPERATIONS AND INCREASE PATIENT VISITS AT ALL CLINICS.SELECTED ACCOMPLISHMENTS:- THERE ARE NO CURRENT PLANS TO OPEN NEW AFFILIATE LOCATIONS.- NEW CANCER PATIENTS REFERRED TO ST. JUDE FROM THE AFFILIATES HAS INCREASED EACH YEAR:FY15 104FY16 144 + 38%FY17 166 + 15%- THE SICKLE CELL CLINICAL RESEARCH AND INTERVENTION PROGRAM HAS BEEN OPENED AT THE BATON ROUGE, CHARLOTTE AND PEORIA AFFILIATES ENABLING PATIENTS TO BENEFIT FROM THE PROTOCOL WHILE STAYING IN THEIR HOME COMMUNITIES.- THE NUMBER OF PATIENTS ENROLLED IN ST. JUDE PRIMARY THERAPEUTIC PROTOCOLS FROM THE AFFILIATE CLINICS HAS INCREASED EACH YEAR:FY15 62 FY16 69 +11%FY17 106 +54%AIM #2 ENHANCING COORDINATION OF CAREPEDIATRIC HEALTH NEED:PHYSICIAN COORDINATION OF CAREHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITALST. JUDE AFFILIATE INSTITUTIONSALL DOMESTIC AND INTERNATIONAL REFERRING CLINICIANS AND CENTERSANTICIPATED OUTCOME:IMPROVE CONTINUITY OF CARE BY ENHANCING COMMUNICATION TOOLS AND EFFORTS TO PROVIDE PHYSICIANS WITH UNPARALLELED ACCESS TO PATIENT INFORMATIONACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. CONTINUE TO IMPROVE THE CLINICIAN PORTAL TO PERMIT REFERRING AND AFFILIATED PHYSICIANS' CONVENIENT ACCESS TO PATIENT INFORMATION, IN ACCORDANCE WITH APPLICABLE LAW.SELECTED ACCOMPLISHMENTS:- CLINICIAN PORTAL WORK IS ONGOING. EXTERNAL PHYSICIAN TESTING HAS BEEN COMPLETED AND FEEDBACK HAS BEEN RECEIVED. - IN A LIMITED SCOPE, ST. JUDE PROVIDERS NOW HAVE THE ABILITY VIA DIRECT EMAIL (ENCRYPTED PROVIDER DIRECTORY DEVELOPED FOR SECURE DATA EXCHANGE) TO SEND AN ELECTRONIC SUMMARY OF CARE, ALONG WITH OTHER DOCUMENTS AS ATTACHMENTS, TO OUTSIDE PHYSICIANS TO WHOM WE ARE REFERRING OUR PATIENTS. WE WILL ALSO BE ABLE TO RECEIVE AN ELECTRONIC TRANSITION OF CARE DOCUMENT FROM OUTSIDE PROVIDERS AND AFFILIATES WHO ARE REFERRING A PATIENT TO ST. JUDE. THIS WILL BE ROLLING OUT IN A LIMITED AVAILABILITY THROUGH THE END OF THE YEAR SINCE IT REQUIRES OUTSIDE PROVIDERS TO HAVE A SPECIAL SECURE CONNECTION. - PROVIDERS IN THE AFFILIATE PROGRAM NOW HAVE ACCESS TO THEIR PATIENTS' ST. JUDE ELECTRONIC MEDICAL RECORD. PEDIATRIC HEALTH NEED:TRANSITION OF PATIENTS FROM PEDIATRIC TO ADULT HEALTHCARE SERVICESHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, DEPARTMENT OF HEMATOLOGY, CLINICAL HEMATOLOGY DIVISIONDIGGS-KRAUS SICKLE CELL CENTER AT REGIONAL ONE HEALTHMETHODIST HEALTHCARE COMPREHENSIVE SICKLE CELL CENTER (MCSCC)ANTICIPATED OUTCOME:INCREASE THE NUMBER OF PATIENTS WITH SICKLE CELL DISEASE WHO ESTABLISH SUSTAINED ADULT CARE AFTER LEAVING PEDIATRIC CARE AT ST. JUDEACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. CONTINUE TO WORK WITH ADULT SICKLE CELL CENTERS IN THE COMMUNITY TO ENHANCE A SEAMLESS TRANSITION FROM PEDIATRIC CARE.2. ENHANCE ADOLESCENT AND YOUNG ADULTS (AYA) TRANSITION CLINICS WITH CO-LOCATION OF PEDIATRIC AND ADULT HEMATOLOGY PROVIDERS.3. AUGMENT FORMAL PROGRAMMING AND PLANNING PROCESSES FOR ADOLESCENTS WITH HEMATOLOGIC AND ONCOLOGIC DISEASES, THROUGH DEVELOPMENT OF DISEASE EDUCATIONAL CURRICULUM AND TRAINING MODULES TO FOSTER INCREASED ADOLESCENT AUTONOMY AND MEDICAL LITERACY.SELECTED ACCOMPLISHMENTS:- WE CONTINUE TO OFFER THE TRANSITION TOUR QUARTERLY TO THE TWO ADULT CENTERS. WE ALSO CONTINUE TO PROVIDE CONTINUED COMMUNICATIONS WITH ADULT PROVIDERS TO OFFER PATIENT TRANSFER DATA TO AVOID INTERRUPTION IN CARE PLAN. WE ALSO HAVE PROVIDED TRAINING FOR METHODIST ADULT PROVIDER (NURSE PRACTITIONER) AT ST. JUDE TO ENSURE CONSISTENCY IN CARE PRACTICE.- IMPROVED COMMUNICATION BETWEEN EMERGENCY ROOM DOCTORS/STAFF AND DOCTORS/STAFF IN THE ADULT SICKLE CELL CENTER. CONTINUED TO HAVE OVERLAP IN PEDIATRIC AND ADULT CARE ON TWO LEVELS: PHYSICIAN (PEDIATRIC HEMATOLOGIST) AND CARE COORDINATION (TRANSITION NURSE CASE MANAGER) WHO WORK WITH BOTH THE PEDIATRIC AND ADULT SICKLE CELL POPULATION.- MANY INITIATIVES HAVE BEEN IMPLEMENTED TO ENHANCE TRANSITION:TRANSITION READINESS PROGRAMTRANSITION TOUR PROGRAMSKILLS LAB: YOUNG ADULTS ARE TAUGHT HOW TO ACCESS INSURANCE BENEFITS, HOW TO ORDER MEDICATION REFILLS, AND HOW TO SCHEDULE DOCTOR'S APPOINTMENT BY WAY OF ROLE PLAY.AIM #3 IMPROVING CHILD HEALTH STATUS THROUGH HEALTHY LIFESTYLE EDUCATION AND PREVENTION FOR CHILDRENPEDIATRIC HEALTH NEED:CHILD KNOWLEDGE OF CANCER PREVENTION, NUTRITION, OBESITY, AND PHYSICAL ACTIVITYHEALTH FACILITIES INVOLVED:ST. JUDE CHILDREN'S RESEARCH HOSPITAL, GLOBAL PEDIATRIC MEDICINEANTICIPATED OUTCOME:INCREASE THE NUMBER OF STUDENTS AND TEACHERS PARTICIPATING IN ST. JUDE CANCER AND HEALTHY LIVING EDUCATION PROGRAM INCREASE THE KNOWLEDGE THAT CHILDREN HAVE ON CANCER AND HEALTHY LIVING TOPICS (NUTRITION, EXERCISE, SUN PROTECTION, AVOIDING TOBACCO)WITH PRE AND POST QUIZZES IMPROVE ATTITUDES OF CHILDREN TOWARD HEALTHY LIVING PRACTICES (AVOIDING SMOKING, BETTER NUTRITION HABITS, MORE EXERCISE, AVOIDING EXCESSIVE SUN) USING SURVEY INSTRUMENTSACTION ITEMS TO MEET IDENTIFIED HEALTH NEED:1. EVALUATE THE EFFECTIVENESS OF THE ST. JUDE CANCER EDUCATION FOR CHILDREN CURRICULUM AT INCREASING CHILDREN'S KNOWLEDGE OF CANCER AND HEALTHY LIVING TOPICS (NUTRITION, EXERCISE, SUN PROTECTION, AVOIDING TOBACCO). 2. EVALUATE THE EFFECTIVENESS OF THE ST. JUDE CANCER EDUCATION FOR CHILDREN CURRICULUM AT IMPROVING CHILDREN'S ATTITUDES TOWARDS HEALTHY LIVING PRACTICES (AVOIDING SMOKING, BETTER NUTRITION HABITS, MORE EXERCISE, AVOIDING EXCESSIVE SUN). 3. PARTNER WITH LOCAL EDUCATION AGENCIES TO DISSEMINATE CANCER AND HEALTHY LIVING EDUCATIONAL PROGRAMS. 4. EVALUATE THE EFFECTIVENESS OF THE ST. JUDE CANCER EDUCATION FOR CHILDREN CURRICULUM AT IMPROVING CHILDREN'S ATTITUDES TOWARDS HEALTHY LIVING PRACTICES (AVOIDING SMOKING, BETTER NUTRITION HABITS, MORE EXERCISE, AVOIDING EXCESSIVE SUN). 5. PARTNER WITH LOCAL EDUCATION AGENCIES TO DISSEMINATE CANCER AND HEALTHY LIVING EDUCATIONAL PROGRAMS. SELECTED ACCOMPLISHMENTS:- THE ST. JUDE CANCER EDUCATION FOR CHILDREN PROGRAM DEVELOPED AN ELEMENTARY CURRICULUM FOR STUDENTS IN GRADES 3-5 THAT USES EDUCATION AND POSITIVE REINFORCEMENT TO HELP PROMOTE HEALTHY LIFESTYLE CHOICES AND TO REDUCE A CHILD'S LIFETIME RISK OF DEVELOPING CANCER. IT SPECIFICALLY ADDRESSES OBESITY, NUTRITION, SMOKING, AND SUN EXPOSURE, IMPORTANT ISSUES IN PROMOTING CHILDHOOD HEALTH AND PRIMARY CANCER PREVENTION. A FORMAL EVALUATION OF THE CURRICULUM TO DETERMINE THE IMPACT OF THE CURRICULUM ON STUDENT ATTITUDES TOWARDS HEALTHY LIVING TOPICS WAS CONDUCTED. THESE RESULTS WILL BE AVAILABLE IN FY18.THE FOLLOWING PUBLICATIONS RESULTED FROM THIS EVALUATION:AYERS, K., VILLALOBOS, A., LI, Z., KRASIN, M. (2014). THE ST. JUDE CANCER EDUCATION FOR CHILDREN PROGRAM PILOT STUDY: DETERMINING THE KNOWLEDGE ACQUISITION AND RETENTION OF 4TH-GRADE STUDENTS. JOURNAL OF CANCER EDUCATION.AYERS, K., VILLALOBOS, A., LI, Z., QUINTANA, Y., KLOSKY, J. (2016). THE ST. JUDE CANCER EDUCATION FOR CHILDREN PROGRAM: THE IMPACT OF A TEACHER-LED INTERVENTION ON STUDENT KNOWLEDGE GAINS. JOURNAL OF CANCER EDUCATION. |
| - DURING THE 2016-2017 SCHOOL YEAR, THE SCHOOL OUTREACH TEAM WORKED WITH 21 | SCHOOLS AND LOCAL LIBRARIES IN THE MEMPHIS AREA TO DELIVER CANCER AND HEALTHY LIVING EDUCATIONAL PROGRAMS TO OVER 2451 K-12 STUDENTS. THROUGH THESE PARTNERSHIPS, THE SCHOOL OUTREACH TEAM WAS ABLE TO INCREASE THE NUMBER OF STUDENTS AND TEACHERS WHO HAVE PARTICIPATE IN THE ST. JUDE CANCER EDUCATION FOR CHILDREN PROGRAM (TABLE 1).TABLE 1: THE NUMBER OF TEACHERS AND STUDENTS WHO PARTICIPATED IN EDUCATIONAL PROGRAMSSCHOOL YEAR NUMBER OF TEACHERS NUMBER OF STUDENTS 2012-2013 65 1,0142013-2014 143 9902014-2015 245 1622015-2016 115 1,7612016-2017 131 2,451IN ADDITION, THE SCHOOL OUTREACH TEAM PARTNERED WITH THE SHELBY COUNTY SCHOOLS' SUPERINTENDENT'S SUMMER LEARNING ACADEMY TO PROVIDE CANCER EDUCATION TO 1781 STUDENTS AT 12 SCHOOLS IN THE MEMPHIS AREA DURING THE 2017 SUMMER MONTHS. |
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL: | PART V, SECTION B, LINE 7A: THE CHNA REPORT WAS MADE WIDELY AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/FINANCIALS/COMMUNITY-HEALTH-NEEDS-ASSESSMENT.HTMLST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 10A: THE HOSPTIAL FACILITY'S MOST RECENTLY ADOPTED IMPLEMENTATION STRATEGY IS AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/FINANCIALS/COMMUNITY-HEALTH-NEEDS-ASSESSMENT.HTMLST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 14: ST. JUDE CURRENTLY DOES NOT BILL NOR PURSUE PAYMENT FOR ANY ST. JUDE PATIENT; THEREFORE, ST. JUDE DOES NOT HAVE A BASIS FOR CALCULATING AMOUNTS CHARGED TO PATIENTS.ST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 16A: THE FAP WAS MADE WIDELY AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTMLST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 16B: BASED ON THE FINANCIAL ASSISTANCE STATEMENT (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-STATEMENT.HTML) AND FINANCIAL ASSISTANCE POLICY (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTML), ST. JUDE DOES NOT HAVE AN APPLICATION FORM.ST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 16C: A PLAIN LANGUAGE SUMMARY WAS MADE WIDELY AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-STATEMENT.HTML |
Supplemental Information Detail SupplementalInformationDetail (14 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 3C: | NO FAMILY EVER PAYS ST. JUDE FOR TREATMENT. WE DO NOT NEED TO DETERMINE ELIGIBILITY FOR THIS ASSISTANCE. BY DEFAULT, ALL PATIENTS ARE ELIGIBLE TO RECEIVE MEDICAL CARE AND SUPPORT SERVICES AT NO COST. ALL PATIENTS ACCEPTED FOR ST. JUDE TREATMENT RECEIVE CARE WHETHER OR NOT THEY OR THEIR FAMILIES CAN PAY FOR IT. ST. JUDE DOES HAVE A BILLING SYSTEM, BUT PATIENTS DO NOT RECEIVE BILLS. IF THE PATIENT HAS INSURANCE, ST. JUDE BILLS THE INSURANCE PLAN OR OTHER ORGANIZATION THAT PAYS HEALTH COSTS. BILLING INSURANCE FOR THE COSTS THAT WOULD BE DUE AT ANY OTHER HOSPITAL ALLOWS ST. JUDE TO CONTINUE DOING SOME OF THE MOST ADVANCED RESEARCH IN THE WORLD. IT ALSO ALLOWS ST. JUDE TO PAY FOR TREATMENTS, COPAYMENTS, DEDUCTIBLES, COINSURANCE, AND ANY OTHER COSTS INSURANCE DOES NOT COVER. TO ENSURE FAMILIES ARE MAKING USE OF ALL RESOURCES FOR WHICH THEY ARE ELIGIBLE, WE HAVE PROGRAMS TO ASSIST FAMILIES IN ENROLLING IN VARIOUS PUBLIC ASSISTANCE PROGRAMS FOR WHICH THEY MAY QUALIFY, INCLUDING BUT NOT LIMITED TO TENNCARE/MEDICAID, COVERKIDS, CHIPS AND SOCIAL SECURITY. DOING SO ENSURES AN APPROPRIATE SAFETY NET SHOULD THE FAMILY SEEK TREATMENT OUTSIDE OF ST. JUDE AND IT ALLOWS US TO BE GOOD STEWARDS OF DONOR DOLLARS. WE ALSO CONTRACT WITH A VENDOR TO PROVIDE CERTIFIED APPLICATION COUNSELOR SERVICES TO ASSIST FAMILIES APPLYING FOR HEALTH INSURANCE COVERAGE THROUGH FEDERAL OR STATE FACILITATED MARKETPLACE. |
| PART I, LINE 7: | COST-TO-CHARGE RATIO DERIVED FROM WORKSHEET 2, RATIO OF PATIENT CARE COST TO CHARGES. COST-TO-CHARGE RATIO USED FOR LINE 7A FINANCIAL ASSISTANCE AT COST, LINE 7B MEDICAID, AND LINE 7C COSTS OF OTHER MEANS-TESTED GOVERNMENT PROGRAMS.SOME CHIPS VOLUME IS INCLUDED IN MEDICAID IN PART I, LINE 7B BECAUSE IN MANY STATES THE CHIPS PROGRAMS ARE MANAGED BY THE SAME THIRD PARTY ADMINISTRATORS, AND IT IS DIFFICULT TO DISTINGUISH BETWEEN CHIPS AND MEDICAID COVERAGE. |
| PART I, LINE 7G: | ST. JUDE CHILDREN'S RESEARCH HOSPITAL INCLUDED AS SUBSIDIZED HEALTH SERVICES SUPPORT FOR EIGHT AFFILIATE CLINICS TOTALING APPROXIMATELY $8.9 MILLION. |
| PART II, COMMUNITY BUILDING ACTIVITIES: | THE ST. JUDE CHILDREN'S RESEARCH HOSPITAL CEO IS A MEMBER OF MEMPHIS TOMORROW. MEMPHIS TOMORROW IS AN ASSOCIATION OF CHIEF EXECUTIVE OFFICERS OF MEMPHIS' LARGEST ENTERPRISES. THE PURPOSE IS TO BRING TOP BUSINESS LEADERS TOGETHER WITH GOVERNMENT AND CIVIC LEADERS TO FOSTER ECONOMIC PROSPERITY FOR ALL WHO LIVE IN OUR COMMUNITY. THEIR INITIATIVES ARE FOCUSED IN THOSE AREAS WHICH DIRECTLY IMPACT ECONOMIC GROWTH AND OPPORTUNITY, INCLUDING: HUMAN CAPITAL DEVELOPMENT, INDUSTRY DEVELOPMENT, AND PUBLIC SAFETY. ST. JUDE ALSO PARTICIPATES WITH MEMPHIS FAST FORWARD WHOSE STRATEGIES ARE BASED ON THE COMMON SENSE PREMISE THAT ECONOMIC GROWTH AND PROSPERITY, AND IMPROVED QUALITY OF LIFE, WILL FOLLOW ONCE MEMPHIS AND SHELBY COUNTY SUCCESSFULLY ADDRESS THE BASICS: GOOD JOBS, QUALITY EDUCATION, SAFE STREETS AND EFFICIENT GOVERNMENT. ST. JUDE IS A MEMBER OF THE ASPIRING FOR PURCHASING EXCELLENCE (APEX) ASSOCIATION OF MEMPHIS. APEX IS AN ASSOCIATION OF PURCHASING AND PROCUREMENT PROFESSIONALS FROM MEMPHIS ORGANIZATIONS WHOSE PURPOSE IS TO PROMOTE BEST PRACTICES IN SUPPLIER DIVERSITY. ADDITIONALLY, ST. JUDE IS SILVER SPONSOR FOR THE MID-SOUTH MINORITY BUSINESS COUNCIL (MMBC) ECONOMIC DEVELOPMENT FAIR. THE MMBC SERVES AS THE MID-SOUTH'S FOREMOST MINORITY BUSINESS DEVELOPMENT ORGANIZATION. THE MMBC HELPS TO DEVELOP A STRONG MINORITY AND WOMEN BUSINESS COMMUNITY IN AN EFFORT TO IMPACT ECONOMICALLY THE ENTIRE MID-SOUTH REGION. THE ST. JUDE OFFICE OF GOVERNMENT AFFAIRS DIRECTOR CONTINUES TO SERVE ON THE BOARD OF DIRECTORS OF THE RIVERFRONT DEVELOPMENT CORPORATION (RDC). THE RDC MANAGES ALL THE PARKS ALONG A 5-MILE STRETCH OF THE MEMPHIS RIVERFRONT INCLUDING ALONG DOWNTOWN MEMPHIS AND MUD ISLAND RIVER PARK. ELEMENTS ALONG THE RIVER FOSTER HEALTHY LIFESTYLES INCLUDING RIVERFIT, A SERIES OF PHYSICAL FITNESS CHALLENGES, AND A PLAYGROUND DESIGNED SPECIFICALLY FOR CHILDREN AT BEALE ST. LANDING, THE ONLY CHILD-DESIGNATED PLAYGROUND ON THE MEMPHIS RIVERFRONT. THE RDC IS ALSO WORKING WITH THE CITY OF MEMPHIS TO IMPLEMENT A SERIES OF IMPROVEMENTS DESIGNED TO TIE THE RIVERFRONT CLOSER TO WORKERS AND RESIDENTS OF DOWNTOWN MEMPHIS TO MAKE ACCESS TO RIVERFRONT AMENITIES EASIER FOR ALL CITIZENS OF MEMPHIS AND TOURISTS VISITING THE CITY.THE PEDIATRIC ONCOLOGY EDUCATION PROGRAM BRINGS FIFTY TO SIXTY STUDENTS EACH SUMMER FOR INTERNSHIPS IN BASIC SCIENCE OR CLINICAL RESEARCH. ADDITIONALLY, EXPERIENTIAL LEARNING INTERNSHIPS ARE STRUCTURED BY AND MANAGED BY ACADEMIC PROGRAMS IN MANY AREAS FROM SCIENCE TO ACCOUNTING. THERE ARE ANOTHER 150 STUDENTS INVOLVED IN THESE INTERNSHIPS. THESE PROGRAMS SUPPORT INCREASING THE AWARENESS OF CAREERS IN RESEARCH SCIENCE, HEALTHCARE, OR HEALTHCARE MANAGEMENT AND CONTRIBUTE TO PREPARING STUDENTS TO ENTER THESE CAREERS. THE CLINICAL EDUCATION AND TRAINING OFFICE HOSTS THIRTY TO FORTY STUDENTS ANNUALLY AS PATIENT CARE OBSERVERS. THESE STUDENTS ARE AT DIFFERENT STAGES OF TRAINING FROM UNDERGRADUATE COLLEGE OR PROFESSIONAL HEALTHCARE SCHOOLS INCLUDING MEDICAL SCHOOLS. THE OBSERVERS ARE DECIDING ON OR CONFIRMING CAREER HEALTHCARE DECISIONS.THE VOLUNTEER SERVICES DEPARTMENT PROVIDES SUMMER PROGRAMS FOR HIGH SCHOOL AND COLLEGE STUDENTS THAT DRIVE ENTRY INTO HEALTH CAREERS.THE OFFICE OF LEGAL SERVICES OFFERS LEGAL INTERNSHIPS TO LOCAL (UNIVERSITY OF MEMPHIS, OLE MISS) LAW STUDENTS DURING THE ACADEMIC YEAR AND TO NATIONAL LAW SCHOOLS DURING THE SUMMER. INTERNS PERFORM LEGAL RESEARCH; DRAFT MEMORANDA, LETTERS, AND OTHER DOCUMENTS; DRAFT AND REVIEW CONTRACTUAL AGREEMENTS; PREPARE PRESENTATIONS TO ST. JUDE PERSONNEL; AND ASSIST WITH IDENTIFYING LEGAL FRAMEWORK FOR POLICIES. INTERNS ALSO LEARN THROUGH OBSERVATION OF AND PARTICIPATION IN DAY-TO-DAY LAW PRACTICE ACTIVITIES, INCLUDING LEGAL PROCEEDINGS, NEGOTIATIONS, MEETINGS, TRAININGS, AND COUNSELING SESSIONS. WHEN POSSIBLE, INTERNS WORK WITH CLIENT DEPARTMENTS AND DEPARTMENTAL STAFF TO GATHER INFORMATION AND TO GAIN INSIGHT INTO AND UNDERSTANDING OF RESEARCH, CLINICAL, BUSINESS, AND HEALTH CARE OPERATIONS.THE CHIEF LEGAL OFFICER PARTICIPATES ON COMMITTEES OF THE MEMPHIS CHILD ADVOCACY CENTER, WHICH HELPS LOCAL CHILDREN FIND SAFETY AND HEALING (INCLUDING ACCESS TO A MENTAL HEALTH PROFESSIONAL) AFTER A REPORT OF SEXUAL OR OTHER SEVERE ABUSE, AND OFFERS ABUSE PREVENTION TRAINING TO COMMUNITY VOLUNTEERS AND PARENTS.THE CHIEF LEGAL OFFICER SERVES AS CHAIR OF THE ADVISORY BOARD OF THE INSTITUTE FOR HEALTH LAW & POLICY OF THE CECIL C. HUMPHREYS UNIVERSITY OF MEMPHIS SCHOOL OF LAW, WHICH ENDEAVORS TO ADDRESS UNMET HEALTH LAW NEEDS OF THE LOCAL COMMUNITY AND WORK WITH COMMUNITY LEADERS TO PROACTIVELY ADDRESS HEALTH POLICY NEEDS.THE SENIOR ASSOCIATE COUNSEL IS THE MEMPHIS BAR ASSOCIATION HEALTH LAW SECTION'S ELECTED REPRESENTATIVE TO THE BOARD OF THE MEMPHIS BAR ASSOCIATION. THE CHIEF LEGAL OFFICER CHAIRS THE COMMUNITY AFFAIRS COMMITTEE OF THAT SECTION AND THE ASSOCIATE COUNSEL IS AN ACTIVE MEMBER OF THE COMMITTEE, WHICH ANNUALLY SPONSORS A SATURDAY LEGAL CLINIC PROVIDING UNREPRESENTED MEMBERS OF THE COMMUNITY AN OPPORTUNITY TO MEET WITH A VOLUNTEER ATTORNEY AND DISCUSS LEGAL ISSUES, INCLUDING THOSE THAT HAVE AN IMPACT ON PERSONAL HEALTH.THE MANAGER OF THE CANCER EDUCATION PROGRAM IN THE DEPARTMENT OF GLOBAL PEDIATRIC MEDICINE (GPM) DEDICATES 80% OF HER TIME TO CANCER EDUCATION OUTREACH, INCLUDING ACTIVITIES SUCH AS K-12 CURRICULUM DEVELOPMENT, SCHOOL VISITS FOR CANCER AND HEALTHY LIVING EDUCATION, CAREER TALKS, TEACHER TRAINING WORKSHOPS AND PUBLIC-ACCESS WEBSITE DEVELOPMENT. |
| PART III, LINE 2: | BAD DEBT EXPENSE IS EQUAL TO CHARGES ON ACCOUNTS DETERMINED TO BE UNCOLLECTIBLE. SEE NARRATIVE FOR PART 1, LINE 3C REGARDING THE ORGANIZATION'S FINANCIAL ASSISTANCE POLICY. |
| PART III, LINE 4: | BAD DEBT EXPENSE EXPLANATION IN FINANCIAL STATEMENTS FOOTNOTES IS AS FOLLOWS:NET PATIENT SERVICE REVENUES AND RECEIVABLES. NO FAMILY EVER PAYS THE HOSPITAL FOR THE CARE THEIR CHILD RECEIVES. ACCORDINGLY, NET PATIENT SERVICE REVENUE CONSISTS ONLY OF ESTIMATED NET REALIZABLE AMOUNTS FROM THIRD-PARTY PAYORS FOR SERVICES RENDERED, INCLUDING ESTIMATED RETROACTIVE REVENUE ADJUSTMENTS (IF NECESSARY) DUE TO FUTURE AUDITS, REVIEWS, AND INVESTIGATIONS. RETROACTIVE ADJUSTMENTS ARE CONSIDERED IN THE RECOGNITION OF REVENUE ON AN ESTIMATED BASIS IN THE PERIOD THE RELATED SERVICES ARE RENDERED, AND SUCH AMOUNTS ARE ADJUSTED IN FUTURE PERIODS AS ADJUSTMENTS BECOME KNOWN OR AS YEARS ARE NO LONGER SUBJECT TO SUCH AUDITS, REVIEWS, AND INVESTIGATIONS. PATIENT SERVICE REVENUE HAS BEEN REDUCED BY ADJUSTMENTS FOR UNCOLLECTIBLE ACCOUNTS TOTALING APPROXIMATELY $512,000 AND $1,629,000 IN 2017 AND 2016, RESPECTIVELY.ST. JUDE CHILDREN'S RESEARCH HOSPITAL DOES NOT CONSIDER BED DEBT EXPENSE A COMMUNITY BENEFIT. |
| PART III, LINE 8: | ST. JUDE CHILDREN'S RESEARCH HOSPITAL DOES NOT CONSIDER THE MEDICARE SHORTFALL A COMMUNITY BENEFIT. THE COST TO CHARGE RATIO WAS USED TO DETERMINE MEDICARE ALLOWABLE COSTS OF CARE. |
| PART III, LINE 9B: | ALL PATIENTS ACCEPTED FOR ST. JUDE TREATMENT RECEIVE CARE WHETHER OR NOT THEY OR THEIR FAMILIES CAN PAY FOR IT. ST. JUDE DOES HAVE A BILLING SYSTEM, BUT PATIENTS DO NOT RECEIVE BILLS. IF THE PATIENT HAS INSURANCE, ST. JUDE BILLS THE INSURANCE PLAN OR OTHER ORGANIZATION THAT PAYS HEALTH COSTS. THIS IS SET FORTH IN OUR FINANCIAL ASSISTANCE STATEMENT (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-STATEMENT.HTML) AND FINANCIAL ASSISTANCE POLICY (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTML). |
| PART VI, LINE 2: | ST. JUDE'S PRIMARY CLINICAL EFFORT CENTERS ON PROVIDING GROUND-BREAKING, RESEARCH-DRIVEN TREATMENTS FOR CHILDHOOD CANCERS AND OTHER CATASTROPHIC DISEASES IN CHILDREN. CANCERCHILDHOOD CANCERS ARE RARE. ONLY 10,270 NEW CASES ARE EXPECTED TO OCCUR AMONG CHILDREN 14 YEARS OF AGE AND YOUNGER IN 2017; HOWEVER, CANCER IS THE LEADING CAUSE OF DISEASE RELATED DEATH IN U.S. CHILDREN (FOOTNOTE 1). THE PRINCIPLE FOCUS OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS CANCER. SEVENTY-FIVE PERCENT OF ALL RESOURCES AT ST. JUDE ARE INVESTED IN ELUCIDATING BASIC BIOLOGICAL MECHANISMS OF PEDIATRIC CANCERS, AND TRANSLATING THIS KNOWLEDGE INTO IMPROVED DIAGNOSTIC TOOLS AND CURATIVE THERAPIES, WHILE MINIMIZING LONG-TERM SIDE EFFECTS. SIXTY-SIX PERCENT OF OUR CANCER PATIENTS RESIDE IN THE ST. JUDE CATCHMENT AREA WHICH INCLUDES A 180-MILE RADIUS AROUND ST. JUDE LOCATED IN MEMPHIS, TN AND A 100-MILE RADIUS AROUND EACH OF OUR EIGHT AFFILIATES. THESE EIGHT AFFILIATES ARE LOCATED IN HUNTSVILLE, AL, CHARLOTTE, NC, JOHNSON CITY, TN, BATON ROUGE, LA, SHREVEPORT, LA, TULSA, OK, SPRINGFIELD IL, AND PEORIA, IL. ALL PATIENTS IN OUR CATCHMENT AREA ARE ACCEPTED TO ST. JUDE FOR TREATMENT OF THEIR CANCER REGARDLESS OF WHETHER AN APPROPRIATE CLINICAL TRIAL IS OPEN. THE DISTRIBUTION OF ST. JUDE CANCER CASES IN RELATION TO RACE, ETHNICITY, AND GENDER IS CONSISTENTLY ALIGNED WITH THE GENERAL DEMOGRAPHICS OF THE CATCHMENT AREA (BASED ON 2010 DATA FROM THE US CENSUS BUREAU) AND WITH THE CANCER SPECIFIC DEMOGRAPHICS (BASED ON SURVEILLANCE EPIDEMIOLOGY AND END RESULTS (SEER) 2009 DATA). FOR EXAMPLE, ESTIMATES FROM THE 2009 SEER DATA SUGGEST THAT WHITES COMPRISE 80%, BLACKS 18% AND HISPANICS 8% OF THE PEDIATRIC CANCER CASES IN THE CATCHMENT AREA. IN COMPARISON, 73%, 18%, AND 14.5%, RESPECTIVELY, OF WHITES, BLACKS AND HISPANICS CONSTITUTE OUR CANCER PATIENT POPULATION (FOOTNOTE 2). (NOT EQUAL TO 100% SINCE SUMMARIZES RACE AND ETHNICITY.) DEMOGRAPHICS FROM THE ST. JUDE PEDIATRIC CANCER COHORT ARE COMPARED WITH THE DEMOGRAPHICS OF THE CATCHMENT AREA ANNUALLY TO MONITOR DEMOGRAPHIC REPRESENTATION OF OUR CANCER PATIENTS IN RELATION TO THE AREA THAT WE SERVE. ALSO MONITORED ANNUALLY IS THE DISTRIBUTION OF SPECIFIC CANCERS IN THE CATCHMENT AREA AND COMPARED WITH THE ST. JUDE CANCER POPULATION.OUR RESEARCH AND CLINICAL TRIALS ARE INFORMED BY THE CHILDREN TREATED AT ST. JUDE AND OUR AFFILIATE CLINICS. ST. JUDE OFFERS THERAPEUTIC TRIALS FOR A VARIETY OF CANCERS INCLUDING CENTRAL NERVOUS SYSTEM (CNS) TUMORS, NON-CNS SOLID TUMORS, AND LEUKEMIA/LYMPHOMA. MANY OF THESE TRIALS ARE INSTITUTIONALLY SPONSORED; HOWEVER, ST. JUDE ALSO PARTICIPATES IN A NUMBER OF CLINICAL TRIALS CONSORTIA PROVIDING OUR CANCER PATIENTS ACCESS TO A VARIETY OF THERAPEUTIC STUDIES. PEDIATRIC CANCER PATIENTS MAY EXPERIENCE TREATMENT-RELATED SIDE EFFECTS MANY YEARS AFTER DIAGNOSIS. THE CHILDHOOD CANCER SURVIVOR STUDY AND ST. JUDE LIFE ARE TWO STUDIES, ACTIVE AT ST. JUDE, ASSESSING LATE EFFECTS OF CANCER THERAPY ON PEDIATRIC CANCER SURVIVORS. INFORMATION FROM THESE STUDIES WILL BE USED TO DEFINE RISK GROUPS FOR VARIOUS LATE EFFECTS AND ASSESS INTERVENTIONS.THE RARITY OF PEDIATRIC CANCERS AND OUR UNIQUE POSITION AS A NATIONAL RESOURCE FOR THE RESEARCH AND TREATMENT OF CANCER MEANS THAT OUR REACH IS EXTENSIVE, INCLUDING LOCAL, REGIONAL, NATIONAL, AND INTERNATIONAL LEVELS. MANY OF OUR INITIATIVES ARE DESIGNED TO IMPACT PEDIATRIC CANCER TREATMENT ON A GLOBAL SCALE. THE NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN), A NOT-FOR-PROFIT ALLIANCE OF 27 OF THE WORLD'S LEADING CANCER CENTERS, IS DEDICATED TO IMPROVING THE QUALITY, EFFECTIVENESS AND EFFICIENCY OF CARE PROVIDED TO PATIENTS WITH CANCER (WWW.NCCN.ORG). ST. JUDE, A NCCN MEMBER IN COLLABORATION WITH THE UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER/THE WEST CLINIC, PARTICIPATES IN A NUMBER OF THE VARIOUS COMMITTEES AND GUIDELINES PANELS THAT WORK TOWARD THE GOAL OF IMPROVING THE QUALITY AND EFFECTIVENESS OF CARE PROVIDED TO PATIENTS WITH CANCER. THE NCCN GUIDELINES ARE WIDELY USED IN ONCOLOGY PRACTICE; IN 2016 THE NCCN GUIDELINES WERE DOWNLOADED MORE THAN 6.9 MILLION TIMES.ACCORDING TO THE AMERICAN CANCER SOCIETY, INDIVIDUALS WITH LOWER SOCIOECONOMIC STATUS HAVE HIGHER CANCER INCIDENCE RATES DUE TO ENGAGING IN LIFESTYLE BEHAVIORS THAT INCREASE CANCER RISK (FOOTNOTE 3). THE ST. JUDE CANCER EDUCATION FOR CHILDREN PROGRAM IS A LOCAL COMMUNITY EFFORT THAT USES EDUCATION AND POSITIVE REINFORCEMENT TO PROMOTE HEALTHY LIFESTYLE CHOICES THAT CAN HELP CHILDREN REDUCE THEIR RISK OF CANCER IN ADULTHOOD. EDUCATIONAL COMPONENTS OF THE PROGRAM SPECIFICALLY ADDRESS OBESITY, NUTRITION, SMOKING, AND SUN EXPOSURE, IMPORTANT ISSUES IN PROMOTING CHILDHOOD HEALTH AND PRIMARY CANCER PREVENTION. THE PROGRAM DEVELOPMENT IS OVERSEEN BY A MULTIDISCIPLINARY TEAM COMPOSED OF ST. JUDE FACULTY AND STAFF, LOCAL EDUCATORS, AND LOCAL HEALTH EXPERTS WHO WORK TOGETHER TO ENSURE THAT THE CONTENT ACHIEVES THE GOALS OF THE PROGRAM WHILE ALIGNING TO STATE AND NATIONAL EDUCATION STANDARDS. DURING THE 2016-2017 SCHOOL YEAR, THE SCHOOL OUTREACH TEAM WORKED WITH 29 SCHOOLS AND 8 COMMUNITY ORGANIZATIONS IN THE MEMPHIS AREA TO DELIVER CANCER AND HEALTHY LIVING EDUCATION PROGRAMS TO OVER 2,400 K-12 STUDENTS. OF THE 29 SCHOOLS THAT PARTICIPATED IN THE PROGRAM, 21 WERE TITLE 1 SCHOOLS; THIS PARTICIPATION IS IMPORTANT BECAUSE OF THE HIGH PERCENTAGE OF CHILDREN ENROLLED FROM LOW SOCIOECONOMIC FAMILIES. HEMATOLOGYTHE GEOGRAPHIC CATCHMENT AREA FOR ST. JUDE ENCOMPASSES 21 COUNTIES IN WESTERN TENNESSEE INCLUDING MEMPHIS, AND AREAS IN EAST ARKANSAS, NORTH MISSISSIPPI, AND A FEW COUNTIES IN MISSOURI. MORE THAN 70,000 PEOPLE IN THE UNITED STATES HAVE SICKLE CELL DISEASE (SCD), AND IT IS ESTIMATED THAT MORE THAN 1 MILLION PEOPLE WORLDWIDE SUFFER FROM THE DISEASE. IT IS THE MOST FREQUENT GENETIC BLOOD DISORDER IN THE WORLD. ST. JUDE HAS ONE OF THE LARGEST PEDIATRIC SCD PROGRAMS IN THE COUNTRY AND PROVIDES COMPREHENSIVE TREATMENT AND EDUCATION TO ABOUT 900 CHILDREN WITH SCD IN THE GEOGRAPHIC CATCHMENT AREA. SCD IS DIAGNOSED BY STATE-WIDE NEWBORN SCREENING IN ALL 50 STATES. ST. JUDE HAS A PARTNERSHIP WITH NEWBORN SCREENING PROGRAMS IN TN AND MS THAT ENSURES A STABLE RELATIONSHIP AMONG PARENTS, PATIENTS, PRIMARY CARE PROVIDERS. ABOUT 50 NEWBORNS WITH SCD ARE IDENTIFIED EACH YEAR IN OUR GEOGRAPHIC CATCHMENT AREA. OUR SCD INFANT TODDLER PROGRAM CONTACTS AND ACCEPTS ALL CHILDREN DIAGNOSED WITH THE DISEASE TO ITS COMPREHENSIVE CARE SERVICE. ADDITIONALLY, ST. JUDE PROVIDES TRAIT COUNSELING SERVICE TO INFANTS BORN WITH SICKLE CELL TRAIT TO 21 COUNTIES IN WESTERN TN. ST. JUDE PROVIDES CONFIRMATORY TESTING, EDUCATION AND COMPREHENSIVE CARE AND FOLLOW-UP THROUGHOUT CHILDHOOD FOR CHILDREN WITH SCD DISEASE. FROM BIRTH TO AGE 18 YEARS, PATIENTS ARE CLINICALLY EVALUATED AT LEAST EVERY 6 MONTHS, RECEIVE EDUCATION AND MULTI-DISCIPLINARY SERVICES ACCORDING TO STANDARDIZED TREATMENT AND EDUCATION GUIDELINES. SERVICES ALSO INCLUDE COMMUNITY OUTREACH AND EDUCATION OF THE LOCAL COMMUNITY. ST. JUDE HAS ESTABLISHED A FORMAL TRANSITION PROGRAM TO ADULT CARE FOR PATIENTS WITH SCD AND PROVIDES SUPPORT TO PATIENTS AND FAMILIES THROUGHOUT THE TRANSITION PROCESS BY WORKING CLOSELY WITH THE ADULT SCD PROGRAMS AT METHODIST UNIVERSITY HOSPITAL AND REGIONAL ONE HOSPITAL. IN THE PAST, THE SCD PROGRAM AT ST. JUDE HAS COLLABORATED WITH SEVERAL FEDERALLY QUALIFIED HEALTH CARE CENTERS, WITH COMMUNITY PRIMARY CARE PHYSICIANS, LATINO MEMPHIS (THE LARGEST HISPANIC SOCIAL AGENCY IN TENNESSEE), WITH THE SICKLE CELL FOUNDATION OF TENNESSEE (A COMMUNITY-BASED SCD ORGANIZATION), AND WITH REGIONAL SCD PROVIDERS TO ENSURE A MEDICAL HOME AND ADEQUATE SOCIAL SUPPORT FOR ALL SCD PATIENTS IN THE AREA. ST. JUDE ASSESSES PATIENT NEEDS THROUGH PARENT AND PATIENT SURVEYS, INTERACTIVE EDUCATION, MATERIALS REVIEW, AND THROUGH GROUP DISCUSSIONS WITH PARENTS AND PATIENTS.ST. JUDE ALSO PROVIDES CLINICAL SERVICES FOR APPROXIMATELY 800 CHILDREN PER YEAR WITH OTHER NON-MALIGNANT HEMATOLOGICAL DISORDERS THROUGH A STRONG RELATIONSHIP WITH LOCAL COMMUNITY PHYSICIANS. CHILDREN FROM THE GEOGRAPHIC CATCHMENT AREA OF ST. JUDE (AS OUTLINED ABOVE) WITH ILLNESSES SUCH AS HEMOPHILIA, APLASTIC ANEMIA, THROMBOSIS, THALASSEMIA, SPHEROCYTOSIS, AND IMMUNE THROMBOCYTOPENIC PURPURA AND OTHER NON-MALIGNANT HEMATOLOGIC DISORDERS ARE REFERRED TO AND RECEIVE STATE-OF THE-ART CARE FROM ST. JUDE PHYSICIANS AND MEDICAL STAFF. ST. JUDE IS ONE OF A SELECT GROUP OF FEDERALLY RECOGNIZED PEDIATRIC HEMOPHILIA TREATMENT CENTERS AND PROVIDES STATE-OF-THE-ART COMPREHENSIVE CARE TO APPROXIMATELY 300 CHILDREN WITH BLEEDING AND THROMBOSIS DISORDERS.(NOTE: THIS NARRATIVE FOR PART VI, LINE 2 IS CONTINUED BELOW.) - SEE PAGE 118/124 |
| PART VI, LINE 3: | AS NOTED IN PART I, LINE 3C, NO FAMILY EVER PAYS ST. JUDE FOR TREATMENT. IN ADDITION, ST. JUDE PROVIDES AN UNPARALLELED LEVEL OF SUPPORT SERVICES AT NO COST TO FAMILIES. WE ALSO HAVE PROGRAMS TO ASSIST FAMILIES IN ENROLLING IN VARIOUS PUBLIC ASSISTANCE PROGRAMS FOR WHICH THEY MAY QUALIFY, INCLUDING BUT NOT LIMITED TO TENNCARE/MEDICAID, COVERKIDS, CHIPS AND SOCIAL SECURITY. DOING SO ENSURES AN APPROPRIATE SAFETY NET SHOULD THE FAMILY SEEK TREATMENT OUTSIDE OF ST. JUDE AND IT ALLOWS US TO BE GOOD STEWARDS OF DONOR DOLLARS. WE UTILIZE AN OUTSIDE CONTRACTOR TO PROVIDE APPLICATION ASSISTANCE. THE HOSPITAL'S FINANCIAL ASSISTANCE STATEMENT (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-STATEMENT.HTML) AND FINANCIAL ASSISTANCE POLICY (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTML) ARE POSTED ON THE HOSPITAL'S WEBSITE AND AVAILABLE AT REGISTRATION. THESE DOCUMENTS ARE AVAILABLE IN ENGLISH AND SPANISH. FOR FAMILIES SPEAKING OTHER LANGUAGES, WE UTILIZE ONSITE INTERPRETER SERVICES AND/OR PROFESSIONAL CONTRACTED TRANSLATION SERVICES. |
| PART VI, LINE 4: | ST. JUDE CHILDREN'S RESEARCH HOSPITAL IN MEMPHIS, TN, IS A SPECIALTY HOSPITAL THAT TREATS PEDIATRIC CATASTROPHIC DISEASES WITH A FOCUS ON CANCER AND BLOOD DISORDERS. PATIENTS AT ST. JUDE ARE REFERRED BY A PHYSICIAN, DIAGNOSED WITH A DISEASE CURRENTLY UNDER STUDY, AND ELIGIBLE FOR A RESEARCH PROTOCOL. ST. JUDE IS THE ONLY PEDIATRIC RESEARCH CENTER FOR CHILDREN WITH CATASTROPHIC DISEASES, INCLUDING CANCER AND BLOOD DISORDERS, WHERE FAMILIES NEVER PAY FOR TREATMENT NOT COVERED BY INSURANCE. IN FACT, NO FAMILY EVER PAYS ST. JUDE FOR ANYTHING. TRANSPORTATION, HOUSING AND FOOD ARE AMONG THE NO-COST SERVICES PROVIDED TO ENSURE FAMILIES COMING TO ST. JUDE CAN FOCUS ON THEIR CHILD. NO CHILD IS EVER DENIED TREATMENT DUE TO RACE, SEX, NATIONALITY, ETHNICITY, RELIGION, OR THE FAMILY'S ABILITY TO PAY. THE COMMUNITY SERVED BY ST. JUDE CAN BEST BE DEFINED BY UNDERSTANDING ST. JUDE'S PATIENT POPULATION AND SCOPE OF CLINICAL SERVICES. ST. JUDE SERVES AS A NATIONAL REFERRAL CENTER FOR CHILDREN WITH CATASTROPHIC DISEASES, SUCH AS CANCER AS WELL AS A LOCAL REFERRAL CENTER FOR CHILDREN WITH CANCER, BLOOD DISORDERS, AND HIV/AIDS. IT DOES NOT ADMIT CHILDREN FOR ANY DIAGNOSTIC GROUPS OUTSIDE OF THESE SERVICES AND DOES NOT OFFER MEDICAL SERVICES BEYOND THOSE NECESSARY TO CARE FOR CHILDREN WITH THESE DISEASES. ST. JUDE DOES NOT HAVE AN EMERGENCY ROOM (ER). A REFERRAL FROM A MEDICAL PROFESSIONAL EXTERNAL TO ST. JUDE, TYPICALLY THE CHILD'S PEDIATRICIAN OR A PEDIATRIC SUBSPECIALIST, IS NECESSARY PRIOR TO ACCEPTING A PATIENT FOR TREATMENT TO ST. JUDE. ST. JUDE'S PRIMARY CLINICAL EFFORT CENTERS ON PROVIDING GROUND-BREAKING, RESEARCH-DRIVEN TREATMENTS. SPECIFICALLY, MORE THAN 7,500 PATIENTS ARE SEEN AT ST. JUDE YEARLY, MOST OF WHO ARE ENROLLED ON CLINICAL TRIALS FOR NEW TREATMENTS DEVELOPED BY ST. JUDE, AND WHO ARE TREATED ON A CONTINUOUS OUTPATIENT BASIS. THE HOSPITAL HAS 67 OPERATIONAL BEDS FOR PATIENTS REQUIRING HOSPITALIZATION DURING TREATMENT. IT SHOULD BE NOTED THAT ST. JUDE HAS DEVELOPED UNIQUE RESOURCES THAT ALLOW A SIGNIFICANT PORTION OF PATIENTS TO BE TREATED AS OUTPATIENTS WHO WOULD BE ADMITTED INTO INPATIENT UNITS AT MOST HOSPITALS. THIS IS ACCOMPLISHED THROUGH PATIENT HOUSING DEDICATED SOLELY TO ST. JUDE PATIENT FAMILIES DESIGNED WITH INFECTION CONTROL MEASURES SUCH AS HEPA FILTRATION, INFECTION-RESISTANT SURFACES AND OTHER MEDICAL SAFEGUARDS THAT ARE NOT AVAILABLE IN HOTELS OR PATIENTS' HOMES. ST. JUDE HAS A NETWORK OF EIGHT AFFILIATED PEDIATRIC HEMATOLOGY/ONCOLOGY CLINICS IN THE U.S., ALLOWING ST. JUDE TO EXTEND CARE AND BENEFITS TO MORE CHILDREN AND INCREASE THE NUMBER OF CHILDREN ABLE TO BE TREATED ON ST. JUDE CLINICAL TRIAL. ST. JUDE ALSO OPERATES AN INTERNATIONAL OUTREACH PROGRAM AIMED AT SHARING KNOWLEDGE AND RESOURCES TO IMPROVE THE SURVIVAL RATE OF CHILDREN WITH CANCER AND HEMATOLOGIC DISEASES WORLDWIDE. ST. JUDE HAS PARTNERSHIPS WITH 24 MEDICAL INSTITUTIONS IN 17 COUNTRIES.THE HOSPITAL'S OUTREACH INCLUDES THE LOCAL MARKET, AFFILIATE INSTITUTIONS, OTHER AREAS OF THE UNITED STATES/U.S. TERRITORIES, AND THE INTERNATIONAL COMMUNITY. THE LOCAL MARKET ENCOMPASSES MEMPHIS, TENNESSEE AND THE SURROUNDING GEOGRAPHIC AREA WITH APPROXIMATELY 28% OF NEW ONCOLOGY PATIENTS RESIDING WITHIN THIS AREA.FY17 NEW CANCER PATIENTSPATIENT ORIGIN % OF TOTALMEMPHIS, TN AND SURROUNDING AREA 28%AFFILIATE REFERRAL 38%NATIONAL REFERRAL (OTHER AREAS OF U.S.) 26%INTERNATIONAL REFERRAL 8%GRAND TOTAL 100%THE ST. JUDE AFFILIATE PROGRAM (AP) IS A NETWORK OF EIGHT AFFILIATED PEDIATRIC HEMATOLOGY/ONCOLOGY CLINICS IN THE U.S., ALLOWING ST. JUDE TO EXTEND CARE AND BENEFITS TO MORE CHILDREN AND INCREASE THE NUMBER OF CHILDREN ABLE TO BE TREATED ON ST. JUDE CLINICAL TRIALS CLOSER TO HOME. THE PHYSICIANS AND STAFF AT THESE SITES WORK IN COLLABORATION WITH THE STAFF AT ST. JUDE TO DELIVER PROTOCOL RELATED CARE OR EVIDENCE BASED TREATMENT WHEN NOT PARTICIPATING IN A TRIAL TO PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS, SO THAT PATIENTS CAN RECEIVE CARE CLOSER TO HOME. AFFILIATES ARE CURRENTLY LOCATED IN BATON ROUGE LA, CHARLOTTE NC, HUNTSVILLE AL, JOHNSON CITY TN, PEORIA IL, SHREVEPORT LA, SPRINGFIELD MO, AND TULSA OK. THE AFFILIATES' ENROLLMENT OF PATIENTS ON ST. JUDE CLINICAL TRIALS HELPS ST. JUDE FIND CURES FASTER AND SAVE MORE CHILDREN. ST. JUDE PROVIDES FINANCIAL SUPPORT FOR CLINICAL OPERATIONS TO ENSURE EXCELLENT QUALITY OF CARE THAT MEETS ST. JUDE PROTOCOL GUIDELINES AND TO PROVIDE PATIENT ASSISTANCE. THE AP AND OTHER STAFF ASSIST THE AFFILIATES IN THE DEVELOPMENT OF NEW PEDIATRIC HEMATOLOGY-ONCOLOGY PROGRAMS; PROVIDE MONITORING AND CONSULTATION TO IMPROVE PATIENT CARE AND CLINICAL PROCESSES FOR THE AFFILIATE CLINIC AND CHILDREN'S HOSPITAL; AND PROVIDE NUMEROUS EDUCATIONAL OFFERINGS AND MENTORING FOR AFFILIATE STAFF. IN ADDITION, ST. JUDE HAS MANY PROCESSES TO ENSURE GOOD CONTINUITY OF CARE BETWEEN THE AFFILIATES AND ST. JUDE. THE AFFILIATES' CLINICAL RECORDS FOR SHARED PATIENTS ARE AVAILABLE IN ST. JUDE MEDICAL RECORDS AND EVERY AFFILIATE HAS ACCESS TO ST. JUDE ELECTRONIC MEDICAL RECORDS OF SHARED PATIENTS. THE AFFILIATES ALSO HAVE ACCESS TO ALL ELECTRONIC RESOURCES, E.G. PATIENT EDUCATION MATERIALS, RESEARCH PROTOCOLS, CLINICAL GUIDELINES AND RESOURCES; EVERYTHING ON THE ST. JUDE INTRANET. IN ADDITION TO ASSISTING THE AFFILIATES, ST. JUDE PROVIDES CONSULTATION SERVICES FOR MORE THAN 3,400 NATIONAL AND 800 INTERNATIONAL PHYSICIAN REQUESTS. FOR FY17 PATIENT CONSULTATIONS BY CONTINENT TOTALED 4,191 AS FOLLOWS:CONTINENT NUMBER OF PATIENT CONSULTATIONSNORTH AMERICA 3,470SOUTH AMERICA 161EUROPE 198AFRICA 32ASIA 278AUSTRALIA 52TOTAL 4,191ST. JUDE ALSO OPERATES AN INTERNATIONAL OUTREACH PROGRAM IN GPM, AIMED AT IMPROVING SURVIVAL RATES OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES WORLDWIDE. ST. JUDE ACCOMPLISHES THIS BY SHARING KNOWLEDGE, TECHNOLOGY AND ORGANIZATIONAL SKILLS, IMPLEMENTING NEW APPROACHES TO TREAT PEDIATRIC CANCER GLOBALLY, AND GENERATING INTERNATIONAL NETWORKS COMMITTED TO ERADICATING CANCER IN CHILDREN. THERE ARE AN ESTIMATED 175,000 NEWLY DIAGNOSED CASES OF CHILDHOOD CANCER WORLDWIDE EACH YEAR, AND 84% OCCUR IN LOW- AND MIDDLE-INCOME COUNTRIES. CANCER IS EMERGING AS A MAJOR CAUSE OF CHILDHOOD DEATH IN ALL DEVELOPING COUNTRIES, REPLACING OTHER CAUSES OF CHILDHOOD MORTALITY (E.G. HIV, MALNUTRITION, INFECTIONS). DESPITE VAST IMPROVEMENTS IN THERAPY AND SURVIVAL IN HIGH-INCOME COUNTRIES OVER THE PAST 30 YEARS, AN ESTIMATED 60% DO NOT HAVE ACCESS TO ADEQUATE DIAGNOSIS AND MODERN CARE. ST. JUDE STRIVES TO ADDRESS THE NEEDS OF THOSE CHILDREN IN COUNTRIES THAT LACK SUFFICIENT RESOURCES AND HELP THEM MANAGE THEIR OWN BURDEN OF CASES EFFECTIVELY. WHILE SICK CHILDREN FROM AROUND THE WORLD HAVE TRAVELED TO OUR HOSPITAL IN MEMPHIS, RECEIVING TREATMENT IN THEIR OWN COUNTRIES IS MORE EFFICIENT AND LESS DISRUPTIVE FOR THEM AND THEIR FAMILIES. AS A RESULT OF OUR INTERNATIONAL EFFORTS, WE ARE ABLE TO REACH FAR MORE CHILDREN THAN WOULD EVER BE ABLE TO COME TO MEMPHIS. A BASIC HEALTHCARE INFRASTRUCTURE IS NEEDED TO SUPPORT PEDIATRIC ONCOLOGY PROGRAMS, WHICH IN TURN FURTHER IMPROVES THE DEVELOPMENT OF BASIC HEALTHCARE. AT THE LOCAL LEVEL, GPM DEVELOPS PARTNERSHIPS WITH MEDICAL INSTITUTIONS AND FUND-RAISING ORGANIZATIONS AND FACILITATES THE INVOLVEMENT OF OTHER AND GOVERNMENT ORGANIZATIONS TO SUPPORT KEY PROGRAMS AND THE EDUCATION OF LOCAL PERSONNEL. AT THE REGIONAL LEVEL, GPM DEVELOPS PROGRAMS THROUGH THE USE OF TECHNOLOGY AND FOSTERS REGIONAL AND INTERNATIONAL COLLABORATIONS WITH OTHER PEDIATRIC MEDICAL INSTITUTIONS. THE PRIMARY GOAL IS TO DEVELOP LOCAL AND REGIONAL SELF-SUFFICIENCY. THIS MODEL RESULTS IN SIGNIFICANT OVERALL IMPROVEMENT IN HEALTHCARE FACILITIES, THE LEVEL OF PRACTICE, THE CONFIDENCE OF HEALTHCARE PROVIDERS, AND LOCAL COMMUNITY INVOLVEMENT. ST. JUDE EMPHASIZES THE BUILDING OF REGIONAL EXPERTISE AND DIAGNOSTIC CAPABILITIES, WHICH PROVIDE A CRITICAL MASS OF PROFESSIONALS WHO CONTINUALLY LEARN FROM AND ASSIST EACH OTHER. COST EFFICIENCY IS ALSO REALIZED BECAUSE OF SHARED RESOURCES.ST. JUDE HAS PARTNERSHIPS WITH 24 MEDICAL INSTITUTIONS (AND THEIR SUPPORTING FOUNDATIONS) ACROSS 17 DIFFERENT COUNTRIES - BRAZIL, CHILE, CHINA, COSTA RICA, DOMINICAN REPUBLIC, ECUADOR, EL SALVADOR, GUATEMALA, HAITI, HONDURAS, JORDAN, LEBANON, MEXICO, MOROCCO, NICARAGUA, PHILIPPINES, AND VENEZUELA.(NOTE: THIS NARRATIVE FOR PART VI, LINE 4 IS CONTINUED BELOW.) - SEE PAGE 123/124 |
| PART VI, LINE 5: | ST. JUDE CHILDREN'S RESEARCH HOSPITAL WAS OPENED IN 1962. OUR MISSION IS TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT. CONSISTENT WITH THE VISION OF OUR FOUNDER, DANNY THOMAS, NO CHILD IS DENIED TREATMENT BASED ON RACE, RELIGION OR A FAMILY'S INABILITY TO PAY. OUR VISION IS TO BE THE WORLD LEADER IN ADVANCING THE TREATMENT AND PREVENTION OF CATASTROPHIC DISEASES IN CHILDREN. THIS VISION IS PURSUED BY PROVIDING OUTSTANDING PATIENT CARE; BY CONDUCTING BASIC, TRANSLATIONAL AND CLINICAL RESEARCH DESIGNED TO ELUCIDATE BIOLOGICAL MECHANISMS, UNDERSTAND DISEASE PATHOGENESIS, IMPROVE DIAGNOSIS, ENHANCE TREATMENT OUTCOMES, PREVENT DISEASES AND MINIMIZE ADVERSE CONSEQUENCES OF TREATMENT; AND BY EDUCATING HEALTH CARE AND SCIENTIFIC RESEARCH PROFESSIONALS. THROUGH THESE EFFORTS, WE SEEK TO CURE AND ENHANCE THE QUALITY OF LIFE FOR AN INCREASING NUMBER OF CHILDREN WHO COME TO US FOR TREATMENT BY EXPANDING AND SHARING KNOWLEDGE TO ADVANCE TREATMENT OF CHILDREN WITH CATASTROPHIC DISEASES WORLDWIDE, WHILE DEVELOPING STRATEGIES TO PREVENT CATASTROPHIC DISEASES IN CHILDREN.ST. JUDE COMBINES LABORATORY AND CLINICAL RESEARCH TO ADVANCE THE CARE OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES. THE FOCUS IS ON PROVIDING OUTSTANDING PATIENT CARE RESULTS AND ON RESEARCH FINDINGS THAT TRANSLATE INTO IMPROVED PATIENT OUTCOMES. ST. JUDE HAS AN ACADEMIC FACULTY ENGAGED IN A BROAD SPECTRUM OF RESEARCH, INCLUDING THERAPEUTIC TRIALS, INVESTIGATION OF DISEASE PATHOGENESIS AND DISCOVERY-ORIENTED BASIC RESEARCH.HOSPITAL OPERATIONS ARE OVERSEEN BY A BOARD OF GOVERNORS, MOST OF WHICH ARE NEITHER EMPLOYEES, INDEPENDENT CONTRACTORS, OR THEIR FAMILY MEMBERS. RESEARCH ACTIVITIES ARE REVIEWED ANNUALLY BY A SCIENTIFIC ADVISORY BOARD COMPOSED OF INTERNATIONALLY PROMINENT PHYSICIANS AND SCIENTISTS.ST. JUDE CONTRIBUTED TO THE BUILDING OF A STATE-OF-THE ART NEUROSURGICAL FACILITY FOR TREATING LOCAL PEDIATRIC PATIENTS AND ST. JUDE BRAIN TUMOR PATIENTS. THE FACILITY IS EQUIPPED WITH INTRA-OPERATIVE IMAGING EQUIPMENT (IMRI). WHEN PURCHASED, ONLY TWO NEUROSURGICAL FACILITIES IN THE UNITED STATES PROVIDED PATIENTS WITH THIS LEVEL OF TREATMENT, WHICH ALLOWS IMAGING TO TAKE PLACE DURING SURGICAL PROCEDURES. IMRI EQUIPMENT ALLOWS SURGEONS TO MAKE INFORMED DECISIONS DURING THE SURGERY. LIVE WEB CASTS ALLOW OTHERS TO VIEW PROCEDURES. OUR ASSISTANCE WITH THIS FACILITY HELPS ASSURE THAT CHILDREN IN THE AREA HAVE ACCESS TO THE BEST NEUROSURGICAL TREATMENT AVAILABLE.ST. JUDE COMPLETED THE FIRST PHASE OF THE PEDIATRIC CANCER GENOME PROJECT (PCGP) IN JANUARY 2013 - A COLLABORATION WITH WASHINGTON UNIVERSITY TO FIND CLUES TO THE CAUSES OF CHILDHOOD CANCER AND POTENTIAL NEW TREATMENTS AND CURES. THE PROJECT HAS RESULTED IN GROUNDBREAKING DISCOVERIES IN A NUMBER OF CHILDHOOD CANCERS INCLUDING RETINOBLASTOMA, MEDULLOBLASTOMA, NEUROBLASTOMA, DIFFUSE INTRINSIC PONTINE GLIOMA, TWO AGGRESSIVE FORMS OF LEUKEMIA AND LOW-GRADE GLIOMAS. IN DECEMBER 2012, THE PCGP WAS RECOGNIZED AS ONE OF TIME MAGAZINE'S TOP 10 MEDICAL BREAKTHROUGHS AND, IN 2013, AS ONE OF TIME MAGAZINE'S TOP 100 NEW SCIENTIFIC DISCOVERIES. THE SECOND PHASE OF PCGP EXAMINED THE CANCER SAMPLES FROM 300 CHILDREN AND FOCUSED ON DEFINING MUTATIONS THAT CONTRIBUTE TO TUMOR FORMATION, CHARACTERIZING THE STATE OF THE CANCER CELL'S EPIGENOME AND DESCRIBING HOW IT DIFFERED FROM WHAT IS SEEN IN THE NORMAL CELLS. THE SECOND PHASE ALSO INCLUDED A CLINICAL GENOMICS PROJECT CALLED GENOMES FOR KIDS THAT INVOLVED NEXT-GENERATION SEQUENCING FOR CHILDREN WITH CANCER. WHEN PHASE 2 IS COMPLETE, ST. JUDE HOPES TO HAVE A MODEL FOR HOW TO EXTEND GENOME SEQUENCING TO EVERY CHILDHOOD CANCER PATIENT IN THE UNITED STATES. FROM ITS BEGINNINGS IN 2010, THE PCGP IS THE LARGEST, BROADEST, PRIVATELY FUNDED SEQUENCING PROJECT FOR CHILDREN WITH CANCER AND HAS SEQUENCED MORE THAN 800 MATCHED PAIRS OF TUMOR AND HEALTHY GENOMES FROM YOUNG PATIENTS. THE PCGP HAS PROVIDED NEW DETAILS ABOUT THE MUTATIONS THAT UNDERLIE THE DEVELOPMENT AND GROWTH OF A RANGE OF CHILDHOOD CANCERS, AND HAS LAID THE FOUNDATION FOR IMPROVED DIAGNOSTIC TESTING AND THE NEXT GENERATION OF MORE EFFECTIVE, LESS-TOXIC THERAPIES. THE PROJECT HAS LED TO NEW DIRECTIONS IN RESEARCH INVOLVING HIGH-RISK LEUKEMIA, BRAIN AND SOLID TUMORS AS WELL AS NEW COMPUTATIONAL METHODS THAT HAVE BEEN SHARED FOR FREE WITH THE GLOBAL SCIENTIFIC COMMUNITY.THE CYCLOTRON (PARTICLE ACCELERATOR) AT ST. JUDE ENABLES RESEARCHERS TO TRACK THE GROWTH OF CANCER CELLS, PINPOINT THE PRODUCTION OF NEW DNA BY TUMOR CELLS AND STUDY THE HEARTS OF ADULT PATIENTS RETURNING TO ST. JUDE FOR LIFETIME FOLLOW-UP. THE CYCLOTRON HELPS RESEARCHERS BETTER UNDERSTAND CHILDHOOD CANCER BY ENABLING THEM TO PRODUCE NEW, VERY SHORT-ACTING TRACERS.ST. JUDE USES THE SERVICES OF CHILDREN'S GMP, LLC (OF WHICH ST. JUDE IS THE SOLE MEMBER). CHILDREN'S GMP, LLC, MANAGES AND OPERATES A GOOD MANUFACTURING PRACTICE (GMP) FACILITY THAT ENGAGES IN THE PRODUCTION OF BIOLOGICS AND DRUGS FOR RESEARCH. THE GMP OFFERS RESOURCES TO STUDY RARE DISEASES OVERLOOKED BY PHARMACEUTICAL COMPANIES BECAUSE THERE IS LITTLE PROFIT IN MANUFACTURING DRUGS FOR LESSER-KNOWN DISEASES. THE FACILITY, OPERATING ACCORDING TO APPROVED FDA STANDARDS, ALLOWS DOCTORS TO TAILOR TREATMENTS SPECIFICALLY FOR AN INDIVIDUAL CHILD.THE CELL AND TISSUE IMAGING CENTER INCLUDES ELECTRON MICROSCOPY AND LIGHT MICROSCOPY. THE FACILITY PROVIDES INVESTIGATORS ACCESS TO TRANSMISSION ELECTRON MICROSCOPY, CONFOCAL LASER SCANNING MICROSCOPY, MULTIPHOTON MICROSCOPY, IMAGE ANALYSIS, CELL MICROINJECTION AND LIVE CELL IMAGING. THE FEI TECNAI 20 200KV FEG ELECTRON MICROSCOPE, WHICH CAN MAGNIFY AN OBJECT 700,000 TIMES, IS AT THE HEART OF THIS PROGRAM. THIS TECHNOLOGY ALLOWS RESEARCHERS TO GET A CLOSER LOOK AT CANCER TO BETTER UNDERSTAND HOW IT GROWS AND SPREADS AND RESPONDS TO THERAPY. USING THE ELECTRON MICROSCOPE, RESEARCHERS LEARN HOW CANCER CELLS BREAK AWAY FROM THE TUMOR AND SPREAD THROUGHOUT THE BODY.A NEW PATIENT CARE AND RESEARCH BUILDING ON THE ST. JUDE CAMPUS HOUSES PROTON BEAM RADIATION THERAPY TECHNOLOGY DESIGNED TO DELIVER RADIATION THERAPY FOR TREATING CHILDREN WITH BRAIN TUMORS AND SEVERAL OTHER CHILDHOOD CANCERS. PROTON THERAPY IS LESS DAMAGING TO SURROUNDING HEALTHY TISSUE THAN OTHER CURRENT RADIATION THERAPIES. THIS EQUIPMENT WILL ENABLE ST. JUDE TO PROVIDE THIS THERAPY IN A MORE INTEGRATED MANNER TO OUTPATIENTS AND ALLOW OUR RADIATION ONCOLOGISTS TO LEAD THE DEVELOPMENT OF NEW TREATMENTS WITH PROTONS. OURS WAS THE WORLD'S FIRST PROTON THERAPY CENTER DEDICATED SOLELY TO THE TREATMENT OF CHILDREN.TO FURTHER PALLIATIVE SERVICES IN THE COMMUNITY, ST. JUDE PARTICIPATED WITH LE BONHEUR CHILDREN'S HOSPITAL IN DEVELOPING THE QUALITY OF LIFE FOR ALL KIDS PALLIATIVE PROGRAM FOR SERIOUSLY ILL CHILDREN. HOSPICE STAFF, BOTH IN THE HOME AND IN THE HOSPICE RESIDENCE, PROVIDES INTERDISCIPLINARY CARE TO CHILDREN THROUGHOUT THE ILLNESS TRAJECTORY AND CONCURRENT THERAPIES.ST. JUDE ADMINISTRATIVE LEADERS AND FACULTY MEMBERS OF THE DEPARTMENT OF PHARMACEUTICAL SCIENCES HAVE BEEN AT THE FOREFRONT OF BRINGING NATIONAL ATTENTION TO THE PEDIATRIC CANCER DRUG SHORTAGE TOPIC, ACTIVELY ENGAGING REGULATORY AND LEGISLATIVE BODIES TO UNDERSTAND THE IMPACT THESE DRUG SHORTAGES HAVE ON PEDIATRIC CARE AND RESEARCH. PRESENTATIONS OR WRITTEN TESTIMONY HAVE BEEN PROVIDED TO THE FDA CENTER FOR DRUG EVALUATION AND RESEARCH WORKSHOP, TWO SENATE HEARINGS, AND HEALTH SUBCOMMITTEE OF THE HOUSE COMMITTEE ON ENERGY AND COMMERCE. ST. JUDE FOCUSES ON EDUCATING AND TRAINING THE NEXT GENERATION OF DOCTORS, NURSES, RESEARCHERS AND ACADEMIC LEADERS. FROM PROGRAMS FOR HIGH SCHOOL STUDENTS TO THE POSTDOCTORAL LEVEL, THE HOSPITAL PLAYS A MAJOR ROLE IN PREPARING FUTURE LEADERS OF SCIENCE AND MEDICINE. IN ADDITION TO ONSITE EDUCATION, THE INTERNATIONAL OUTREACH PROGRAM PROVIDES AN EDUCATION AND COLLABORATION WEB SITE, CURE4KIDSTM (WWW.CURE4KIDS.ORG). VIA THE CONNECT2PROTECT PROGRAM, ST. JUDE COLLABORATES WITH CHURCHES, OTHER HEALTH CARE ORGANIZATIONS AND CIVIC GROUPS TO RAISE AWARENESS ABOUT PREVENTING THE SPREAD OF HIV/AIDS. THE PRIMARY TARGET IS THE AFRICAN-AMERICAN COMMUNITY, ALTHOUGH OTHER ETHNIC GROUPS ARE ALSO SERVED INCLUDING ASIAN, CAUCASIAN AND HISPANIC.THE FUNDRAISING SOURCE FOR ST. JUDE IS ALSAC, WHICH RAISES FUNDS SOLELY FOR THE HOSPITAL. BECAUSE OF THE HOSPITAL'S MISSION, PEOPLE NATIONWIDE CONTRIBUTE VIA TENS OF THOUSANDS OF FUNDRAISING EFFORTS. ALSAC CONTRIBUTED $664 MILLION IN FY17 TO SUPPORT ST. JUDE.VOLUNTEERS ENHANCE THE QUALITY OF PATIENT CARE BY PARTNERING WITH CLINICAL STAFF TO PROVIDE AN ADDITIONAL PERSONAL TOUCH. VOLUNTEERS ALSO HELP ENSURE A SAFE ENVIRONMENT. THEY LEND ASSISTANCE AND PROVIDE COMPASSIONATE CONCERN BY OFFERING A LISTENING EAR TO FAMILIES AT A TIME WHEN THEY NEED IT MOST. THEY ARE VITAL AMBASSADORS FOR THE HOSPITAL AND COMMUNITY. |
| PART VI, LINE 2 (CONTINUATION FROM 100/124): | IN ADDITION TO PROVIDING AND CONTINUOUSLY IMPROVING STANDARDIZED CARE TO THESE PATIENT POPULATIONS, ST. JUDE HEMATOLOGY DEDICATES A SIGNIFICANT AMOUNT OF RESOURCES TO CLINICAL, TRANSLATIONAL, AND BASIC RESEARCH TO IMPROVE SURVIVAL AND DECREASE MORBIDITY OF CHILDREN WITH NON-MALIGNANT CHRONIC BLOOD DISEASES. MOST PATIENTS PARTICIPATE IN RESEARCH STUDIES, WHICH HAVE RESULTED IN MAJOR IMPROVEMENTS IN CLINICAL CARE. FOR EXAMPLE, RECENT RESULTS FROM THE BABY HUG TRIAL SHOWED THAT DAILY ORAL HYDROXYUREA IS SAFE AND EFFECTIVE FOR INFANTS AND YOUNG CHILDREN WITH SCD, WHICH LED TO THE RECOMMENDATION OF ITS GENERAL USE IN THIS SUBPOPULATION. ALSO, IN A FIRST-IN-MAN TRIAL, ST. JUDE HEMATOLOGY SHOWED THE SAFETY AND EFFICACY OF A NOVEL GENE TRANSFER AGENT CARRYING THE FACTOR IX GENE FOR TREATMENT OF HEMOPHILIA B; ALL TEN ADULT PARTICIPANTS WITH SEVERE HEMOPHILIA B HAD NO SERIOUS UNEXPECTED SIDE EFFECTS AND ALL PARTICIPANTS SHOWED AN INCREASE IN FACTOR IX LEVELS LEADING TO A SUBSTANTIAL REDUCTION IN THEIR BLEEDING TENDENCY. ADDITIONALLY, ST. JUDE HAS DEVELOPED A VECTOR FOR GENE TRANSFER TO TREAT CHILDREN WITH X LINKED SEVERE COMBINED IMMUNODEFICIENCY (X LINKED SCID) DISEASE WHICH HAS SHOWN PROMISE AS A CURE FOR THE DISEASE. FUTURE EFFORTS WILL CONTINUE TO FOCUS ON FINDING VIABLE CURES AND/OR TREATMENTS TO PREVENT COMPLICATIONS IN CHILDREN WITH SCD AND OTHER NON-MALIGNANT, CHRONIC HEMATOLOGIC DISEASES.HIVIN 1987, ST. JUDE'S FOUNDING FATHER, DANNY THOMAS DECLARED AIDS A CATASTROPHIC ILLNESS. IT WAS THEN THAT THE COMPREHENSIVE HIV CARE AND PREVENTION PROGRAM FOR CHILDREN AND YOUTH WAS ESTABLISHED. THE PROGRAM, LOCATED IN THE MEMPHIS METROPOLITAN STATISTICAL AREA, IS IN A COMMUNITY WHERE IN 2013, 59% OF NEW DIAGNOSES WERE AMONG ADOLESCENT YOUTH. SINCE ITS BEGINNING, THE HIV CLINICAL AND RESEARCH PROGRAM HAS PROVIDED EXCEPTIONAL CARE TO PERINATALLY-INFECTED INFANTS AND CHILDREN AND AN EXCELLENT YOUTH-FOCUSED HIV PROGRAM FOR YOUTH AGES 13 TO 21. THE SERVICES INCLUDE A STANDALONE LABORATORY THAT SUPPORTS THE HIV/AIDS CLINICAL & RESEARCH PROGRAMS, COMPREHENSIVE MEDICAL CARE, CASE MANAGEMENT SERVICES, A FULL PHARMACY, PATIENT ADVOCACY, PSYCHOSOCIAL, AND SPIRITUAL SUPPORT FOR PATIENTS AND THEIR FAMILIES. OUR STRONG COMMUNITY INFRASTRUCTURE, FORMALLY ESTABLISHED 11 YEARS AGO, IS COMMITTED TO THE CAUSE OF HIV EDUCATION AND PREVENTION IN THE COMMUNITY. OUR COMMUNITY COALITION, CONNECT TO PROTECT (C2P), CONTINUES TO HAVE 25 CONSISTENT AND ACTIVE MEMBERS THAT REPRESENT AIDS SERVICE ORGANIZATIONS, LOCAL GOVERNMENT, FAITH-BASED AND SOCIAL SERVICE ORGANIZATIONS. QUARTERLY, THE COALITION MEMBERS CONTINUE TO IDENTIFY AT-RISK YOUTH AND CREATE A PROFILE OF AVAILABLE COMMUNITY RESOURCES BASED ON ELIMINATING BARRIERS TO BEING LINKED TO AND RETAINED IN CARE. IN ADDITION TO DEVELOPING A SOLID HIV PREVENTION PLAN, COALITION MEMBERS, ALONGSIDE OUR CLINICAL RESEARCH STAFF, HAVE CO-FACILITATED AND/OR PARTICIPATED IN APPROXIMATELY 187 EDUCATIONAL AND TESTING EVENTS, IMPACTING OVER 2,500 INDIVIDUALS. WORKING TO ALIGN THE STRATEGIC PLAN WITH THE HIV CONTINUUM OF CARE THAT SPECIFICALLY ADDRESSES YOUTH BARRIERS TO TESTING, SURVEILLANCE REPORTING AND LINKAGE OF NEWLY DIAGNOSED HIV+ YOUTH TO MEDICAL CARE IN RESOURCE POOR COMMUNITIES HAS BEEN A STRONG ASSET TO OUR COMMUNITY INFRASTRUCTURE. FOR THIS CALENDAR YEAR, OUR STRATEGIC MULTISITE INITIATIVE FOR LINKAGE AND ENGAGEMENT (SMILE) INTO CARE EFFORTS RESULTED IN APPROXIMATELY 90% (87/97) OF NEWLY DIAGNOSED HIV+ YOUTH BEING ENGAGED IN MEDICAL CARE AND 95% (83/87) OF THEM BEING RETAINED IN CARE. THIS SUCCESS SPEAKS TO STRATEGIC COMMUNITY MOBILIZATION, PARTNER AGENCY PARTICIPATION AND IMPROVED ACCESS TO CARE FOR NEWLY DIAGNOSED HIV POSITIVE YOUTH. PARTICIPANTS IN THE SMILE PROGRAM RECEIVE ASSISTANCE WITH LINKAGE AND ENGAGEMENT IN CARE SERVICES, SPECIALIZED CASE MANAGEMENT, CRISIS INTERVENTION, AND INDIVIDUALIZED COMMUNITY SERVICE AND RESOURCE REFERRALS AS INDIVIDUAL BARRIERS ARE IDENTIFIED. THE SMILE PROGRAM DATA HAS BEEN USED TO FACILITATE CONTINUED DIALOGUE WITHIN THE C2P COALITION. THE INTEGRATION OF BOTH PROGRAMS HAS ENCOURAGED THE COALITION TO PRIORITIZE ALIGNMENT OF THE STRATEGIC PLAN WITH THE HIV CARE CONTINUUM THEREBY IMPROVING ENGAGEMENT AND RETENTION IN CARE OUTCOMES FOR INDIVIDUALS THAT PARTICIPATE IN THE SMILE PROGRAM.OUR NEWEST COMMUNITY RESEARCH PROTOCOL, HIV PREVENTION TRIALS NETWORK (HPTN) 083, IMPLORES A COMMUNITY BASED PARTICIPATORY RESEARCH (CBPR) APPROACH TO HELP REACH ELIGIBLE AT-RISK YOUTH AND YOUNG ADULTS. WE RECEIVED BUY-IN AND SUPPORT FROM VARIOUS STAKEHOLDERS BY HOSTING COMMUNITY BASED HIV TESTING EVENTS THAT OFFER LINKAGE INTO CARE FOR NEWLY DIAGNOSED HIV+ YOUTH AND LINK TO PRE-EXPOSURE PROPHYLAXIS (PREP) FOR THOSE WHO PRESENT HIV NEGATIVE. THIS PAST YEAR, THE HIV PREVENTION TEAM, SUCCESSFULLY LED 21 STAKEHOLDER/GATEKEEPER MEETINGS THAT FOCUSED ON PLANNING AND COORDINATING SPECIFIC OUTREACH AND EDUCATIONAL STRATEGIES. THIS YIELDED FOUR (2 SMALL AND 2 LARGE SCALE EVENTS (E.G., INFORMAL DINNERS AT STAKEHOLDER FAMILY HOMES, REGIONAL FRATERNITY EVENTS, AND DANCE COMPETITIONS) THAT REACHED OVER 732 YOUTH AND YOUNG ADULTS. AS A RESULT THERE HAVE BEEN APPROXIMATELY 89 INDIVIDUALS APPROACHED AS ELIGIBLE STUDY PARTICIPANTS AND APPROXIMATELY 40 ENROLLED. 1. AMERICAN CANCER SOCIETY. CANCER FACTS & FIGURES 2017. ATLANTA: AMERICAN CANCER SOCIETY; 2017.2. FOR THE PERIOD FROM JULY 1, 2016 TO JUNE 30, 20173. AMERICAN CANCER SOCIETY. CANCER FACTS & FIGURES 2017. ATLANTA: AMERICAN CANCER SOCIETY; 2017. |
| PART VI, LINE 4 (CONTINUATION FROM 109/124): | ST. JUDE WORKS WITH ITS PARTNERS TO DEVELOP EVIDENCED-BASED TREATMENT PROTOCOLS TAILORED TO REGIONAL NEEDS AND RESOURCES. ADDITIONALLY, ST. JUDE PHYSICIANS AND NURSES SERVE AS MENTORS TO CLINICAL PERSONNEL AT PARTNER SITES, PROVIDE LOCAL AND ONLINE TRAINING FOR ONCOLOGY CARE, DIAGNOSIS, AND SUPPORTIVE CARE, AND PARTICIPATE IN ONLINE MEETINGS TO DISCUSS CLINICAL CARE BEST PRACTICES. THE MAJORITY OF ONLINE MEETINGS AND TRAINING ARE PROVIDED VIA ST. JUDE'S WEB-BASED PLATFORM, ST. JUDE CURE4KIDSTM (C4K), A FREE RESOURCE FOR PEDIATRIC ONCOLOGY PROFESSIONALS, SCIENTISTS AND RESEARCHERS, REGARDLESS OF THEIR AFFILIATION WITH ST. JUDE OR ITS PARTNERS. IN ADDITION TO CONTENT THAT INCLUDES MORE THAN 1,500 ONLINE SEMINARS, 37 SELF-PACED COURSES, AND 37 INSTRUCTOR-LED COURSES, C4K PROVIDES ONLINE MEETING AND CONFERENCE SPACE. IN FY17, C4K HAD 63,650 CONTENT VIEWS WITH 4,980 UNIQUE REGISTERED USERS, AND HOSTED 1,956 MEETINGS WITH 8,000 UNIQUE PARTICIPANTS FROM 145 DIFFERENT COUNTRIES; THERE ARE 64 NCI CENTERS THAT PARTICIPATE IN C4K. FINALLY, ST. JUDE PARTNERS WITH LOCAL FUNDRAISING ORGANIZATIONS THAT SUPPORT THE MEDICAL PROGRAMS. THIS MODEL HAS PROVEN TO BE HIGHLY EFFECTIVE IN PROVIDING POOR CHILDREN IN DEVELOPING COUNTRIES ACCESS TO MODERN TREATMENT AND CARE.ST. JUDE IS ALSO A RESEARCH ORGANIZATION, WITH RESEARCH COVERING A BROADER SCOPE OF HEALTH ISSUES THAN THE DISEASES TREATED AS A PRIMARY DIAGNOSIS. |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | 0 | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (11 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| UNIVERSITY OF TENNESSEE | |||||||
| 50 NORTH DUNLAP | MEMPHIS | TN | 38105 | 626001636 | GOVERNMENT ENTITY | $3,239,885 | COLLABORATION AND SUPPORT AGREEMENT |
| SAINT FRANCIS MEDICAL CENTER | |||||||
| 530 NE GLEN OAK AVE | PEORIA | IL | 61637 | 370662569 | 501(C)(3) | $490,909 | OPERATION OF ST. JUDE CLINIC |
| CHURCH HEALTH CENTER OF MEMPHIS | |||||||
| 1350 CONCOURSE AVE SUITE 142 | MEMPHIS | TN | 38104 | 581716113 | 501(C)(3) | $100,000 | FINANCIAL SUPPORT |
| MID-SOUTH MINORITY BUSINESS COUNCIL | |||||||
| 165 MADISON AVE | MEMPHIS | TN | 38103 | 621198163 | 501(C)(6) | $8,500 | SPONSOR CONFERENCE |
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS | |||||||
| 600 13TH STREET NW SUITE 500 | WASHINGTON | DC | 20005 | 582176067 | 501(C)(6) | $6,500 | CONTRIBUTION |
| THE UNIVERSITY OF MEMPHIS FOUNDATION | |||||||
| 635 NORMAL ST ALUMNI CENTER 108 | MEMPHIS | TN | 38152 | 626048540 | 501(C)(3) | $6,000 | SUPPORT SCHOOL OF PUBLIC HEALTH |
| OUR LADY OF THE LAKE REGIONAL MEDICAL CENTER | |||||||
| 777 HENNESY BLVD | BATON ROUGE | LA | 70808 | 720423651 | 501(C)(3) | $1,000,000 | FINANCIAL SUPPORT |
| ASSOCIATION OF PEDIATRIC HEMATOLOGY ONCOLOGY NURSES | |||||||
| 8735 W HIGGINS RD STE 300 | CHICAGO | IL | 60631 | 237446224 | 501(C)(3) | $10,000 | SPONSOR CONFERENCE |
| CHILD LIFE COUNCIL | |||||||
| 1820 N FORT MEYER DR SUITE 520 | ARLINGTON | VA | 22209 | 521799846 | 501(C)(3) | $7,500 | SPONSOR CONFERENCE |
| FASEB SCIENCE RESEARCH | |||||||
| 9650 ROCKVILLE PIKE | BETHESDA | MD | 20814 | 520700497 | 501(C)(3) | $20,000 | SPONSOR CONFERENCE |
| C3 SUMMIT LLC | |||||||
| PO BOX 985 | AMAGANSETT | NY | 11930 | 455047215 | $50,000 | SPONSOR CONFERENCE | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 8 | Total501c3OrgCnt |
| Total Other Org | 3 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS ACTIVELY INVOLVED WITH THE DONEE. THROUGH THIS ACTIVE INVOLVEMENT, THE ORGANIZATIONS ARE MONITORED TO ENSURE THE SUPPORT IS USED APPROPRIATELY. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Travel For Companions | Yes (X) | TravelForCompanionsInd |
| Idemnification Gross Up Pmts | Yes (X) | IdemnificationGrossUpPmtsInd |
| Written Policy Ref T And E Expnss | Yes (1) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (1) | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (1) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (1) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (15 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RICHARD SHADYAC JR | ||||||||||||||
| EX-OFFICIO DIRECTOR | $0 | $769,962 | $0 | $0 | $0 | $2,322 | $0 | $79,563 | $0 | $16,796 | $0 | $868,643 | $0 | $0 |
| JAMES R DOWNING | ||||||||||||||
| PRESIDENT & CEO, EX-OFFICIO DIRECTOR | $910,468 | $0 | $50,000 | $0 | $79,487 | $0 | $29,150 | $0 | $18,039 | $0 | $1,087,144 | $0 | $0 | $0 |
| PAT KEEL | ||||||||||||||
| SVP/CFO | $485,793 | $0 | $90,000 | $0 | $23,128 | $0 | $11,458 | $0 | $18,689 | $0 | $629,068 | $0 | $0 | $0 |
| JAMES I MORGAN | ||||||||||||||
| EVP/SCIENTIFIC DIRECTOR | $475,136 | $0 | $110,200 | $0 | $8,931 | $0 | $29,150 | $0 | $20,480 | $0 | $643,897 | $0 | $0 | $0 |
| MARY ANNA QUINN | ||||||||||||||
| EVP/CHIEF ADMIN OFFICER | $381,557 | $0 | $0 | $0 | $284,193 | $0 | $29,150 | $0 | $41,969 | $0 | $736,869 | $0 | $0 | $0 |
| CHARLES M ROBERTS | ||||||||||||||
| EVP/DIRECTOR CANCER CENTER | $711,738 | $0 | $0 | $0 | $39,108 | $0 | $129,291 | $0 | $14,078 | $0 | $894,215 | $0 | $0 | $0 |
| CARLOS RODRIGUEZ-GALINDO | ||||||||||||||
| EVP/CHAIR | $598,935 | $0 | $150 | $0 | $158,226 | $0 | $27,615 | $0 | $8,481 | $0 | $793,407 | $0 | $0 | $0 |
| DAVID ELLISON | ||||||||||||||
| CHAIR | $649,903 | $0 | $15,350 | $0 | $204,373 | $0 | $51,461 | $0 | $17,762 | $0 | $938,849 | $0 | $0 | $0 |
| THOMAS E MERCHANT | ||||||||||||||
| CHAIR | $708,034 | $0 | $15,350 | $0 | $466,686 | $0 | $29,150 | $0 | $30,408 | $0 | $1,249,628 | $0 | $0 | $0 |
| CHING-HON PUI | ||||||||||||||
| CHAIR | $595,842 | $0 | $28,791 | $0 | $298,375 | $0 | $29,150 | $0 | $50,072 | $0 | $1,002,230 | $0 | $0 | $0 |
| LESLIE L ROBISON | ||||||||||||||
| CHAIR | $559,243 | $0 | $25,350 | $0 | $294,961 | $0 | $29,150 | $0 | $17,980 | $0 | $926,684 | $0 | $0 | $0 |
| ELAINE I TUOMANEN | ||||||||||||||
| CHAIR | $457,452 | $0 | $18,591 | $0 | $274,229 | $0 | $29,150 | $0 | $15,034 | $0 | $794,456 | $0 | $0 | $0 |
| MICHAEL C CANARIOS | ||||||||||||||
| FORMER SVP/CHIEF FINANCIAL OFFICER | $342,205 | $0 | $100,118 | $0 | $23,877 | $0 | $0 | $0 | $17,363 | $0 | $483,563 | $0 | $0 | $0 |
| WILLIAM E EVANS | ||||||||||||||
| FACULTY/FORMER PRES. & CEO | $654,700 | $0 | $15,150 | $0 | $8,790 | $0 | $29,150 | $0 | $8,672 | $0 | $716,462 | $0 | $0 | $0 |
| LARRY KUN | ||||||||||||||
| FORMER EVP/CLINICAL DIRECTOR | $443,211 | $0 | $75,000 | $0 | $6,005 | $0 | $29,150 | $0 | $10,005 | $0 | $563,371 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 1A | TRAVEL FOR COMPANIONS: FAMILY MEMBER OF ONE FORMER OFFICER, TRAVELS ON HOSPITAL BUSINESS AS REQUIRED BY THE POSITION. TRAVEL EXPENSES ARE REIMBURSED UNDER AN ACCOUNTABLE PLAN AND NOT RECORDED AS COMPENSATION. TAX INDEMNIFICATION AND GROSS-UP PAYMENTS: A PAYMENT WAS ISSUED FOR DEPENDENT TUITION FOR ONE OFFICER. THE APPLICABLE EXPENSE WAS GROSSED-UP AND INCLUDED IN THE EMPLOYEE'S W-2 AS ADDITIONAL TAXABLE COMPENSATION. |
| PART I, LINE 4A: | SEVERANCE PAY IN THE AMOUNT OF $344,860 WAS OFFERED TO THE FORMER CHIEF FINANCIAL OFFICER UNDER A SEPARATION AGREEMENT VOLUNTARILY ENTERED INTO BY THE PARTIES. THE TERMS OF THAT AGREEMENT ARE CONFIDENTIAL. ALL SEVERANCE AGREEMENTS CONTAIN, WHEN LEGALLY PERMITTED, A RELEASE OF CLAIMS. |
| PART I, LINE 4B: | THE ORGANIZATION ESTABLISHED A NON-QUALIFIED DEFERRED COMPENSATION PLAN PURSUANT TO CODE SECTION 457(F) OF THE INTERNAL REVENUE CODE. THE PLAN AMOUNTS ARE SUBJECT TO SUBSTANTIAL FUTURE SERVICE REQUIREMENTS TO THE ORGANIZATION AND ARE SUBJECT TO SUBSTANTIAL RISK OF FORFEITURE. PAYMENTS WERE MADE TO THE FOLLOWING LISTED PERSONS IN PART VII UNDER THE NON-QUALIFIED DEFERRED COMPENSATION PLAN DURING THE YEAR: MICHAEL C. CANARIOS - $23,877 CHING-HON PUI - $289,585 MARY ANNA QUINN - $275,360 LESLIE L. ROBISON - $286,030 ELAINE I. TUOMANEN - $265,433 |
| SCHEDULE J, PART II: | RICHARD C. SHADYAC, JR. SERVES AS AN EX-OFFICIO VOTING DIRECTOR OF THE BOARD OF ST. JUDE. MR. SHADYAC IS EMPLOYED AS AN OFFICER OF ALSAC, A RELATED ORGANIZATION TO ST. JUDE. THE COMPENSATION SHOWN IN COLUMNS (B), (C), (D) AND (E) WAS PAID TO MR. SHADYAC BY ALSAC FOR HIS DUTIES AS CEO OF ALSAC. |
Schedule L IRS990ScheduleL
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (3 entries)
| Relationship DescriptionRelationshipDescriptionTxt | TransactionTransactionAmt | TransactionTransactionDesc | Sharing Of RevenuesSharingOfRevenuesInd |
|---|---|---|---|
| MARY RELLING | |||
| SEE PART V | $508,689 | EMPLOYMENT | 0 |
| SUSANNA DOWNING | |||
| SEE PART V | $63,360 | EMPLOYMENT | 0 |
| DIANE ROBERTS | |||
| SEE PART V | $200,935 | EMPLOYMENT | 0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: | FormAndLineReferenceDesc |
| Explanation | (A) NAME OF INTERESTED PERSON: MARY RELLING(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF FORMER OFFICER (PRESIDENT AND CEO), WILLIAM E. EVANS.(C) AMOUNT OF TRANSACTION: $508,689(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO(A) NAME OF INTERESTED PERSON: SUSANNA DOWNING(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF PRESIDENT AND CEO, JAMES R. DOWNING.(C) AMOUNT OF TRANSACTION: $63,360(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO(A) NAME OF INTERESTED PERSON: DIANE ROBERTS(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF OFFICER, CHARLES M. ROBERTS.(C) AMOUNT OF TRANSACTION: $200,935(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (7 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | FAMILY RELATIONSHIP AMONG DIRECTORS: JOSEPH S. AYOUB, JR., ESQ. AND PAUL J. AYOUB, ESQ.; FREDERICK R. HARRIS AND FREDERICK R. HARRIS, JR., MD; GEORGE A. SIMON, II AND PAUL J. SIMON; ROBERT A. BREIT, MD AND JOSEPH G. SHAKER; JOSEPH C. SHAKER AND JOSEPH G. SHAKER; PAUL J. SIMON AND MICHAEL SIMON. |
| FORM 990, PART VI, SECTION A, LINE 4 | EFFECTIVE JUNE 24, 2017, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. AMENDED ITS BYLAWS. THE SIGNIFICANT CHANGES ARE AS FOLLOWS: - BOARD MEMBERS ARE PERMITTED TO BE ELECTED AT ANY REGULARLY SCHEDULED BOARD MEETING; AND - THE AMENDMENT EXTENDS A NEW BOARD MEMBER'S INITIAL TERM TO TWO YEARS, FOLLOWED BY THREE-YEAR TERMS UNLESS THE MEMBERSHIP COMMITTEE RECOMMENDS A DIFFERENT TERM. |
| FORM 990, PART VI, SECTION B, LINE 11B | IN FEBRUARY OF EACH YEAR, THE AUDIT COMMITTEE AND OFFICERS OF THE BOARD ARE PROVIDED WITH A DRAFT COPY OF THE FORM 990 AND ALL REQUIRED SCHEDULES. THE AUDIT COMMITTEE MEETS WITH ITS TAX PREPARER TO REVIEW THE DRAFT FORM 990 BEFORE IT IS FILED WITH THE IRS. ADDITIONALLY THE COMPENSATION COMMITTEE OF THE BOARD IS PROVIDED WITH A DRAFT COPY OF THE COMPENSATION SECTIONS OF THE FORM 990, AND THE CONFLICT OF INTEREST COMMITTEE OF THE BOARD IS PROVIDED WITH A DRAFT COPY OF THE CONFLICT-OF-INTEREST SECTIONS OF THE FORM 990 FOR REVIEW BEFORE THE FINALIZED DOCUMENT IS FILED WITH THE IRS. EACH VOTING MEMBER OF THE BOARD IS PROVIDED WITH A FINAL COPY OF THE FORM 990 AND ALL REQUIRED SCHEDULES BEFORE IT IS FILED WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | NEW BOARD MEMBERS ARE GIVEN A COPY OF THE BOARD OF GOVERNOR'S CONFLICT OF INTEREST POLICY AND COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM. THERE IS A CONFLICT OF INTEREST COMMITTEE OF THE BOARD THAT REVIEWS THE ANNUAL CONFLICT OF INTEREST DISCLOSURE STATEMENTS THAT ARE COMPLETED BY EACH BOARD MEMBER AND DISCUSSES AND RESOLVES CONFLICTS OF INTEREST, WITH OPPORTUNITY FOR APPEAL TO THE FULL BOARD. IN ADDITION, THE ORGANIZATION HAS A CHIEF COMPLIANCE OFFICER AND COMPLIANCE DEPARTMENT, WHICH ADMINISTER THE CONFLICT OF INTEREST DISCLOSURE PROCESS FOR ALL EMPLOYEES IN CLINICAL, RESEARCH, AND SELECT ADMINISTRATIVE DEPARTMENTS, AS WELL AS EMPLOYEES IDENTIFIED AS SUPERVISORS OR WHO HAVE PURCHASING AUTHORITY. ALL SUCH EMPLOYEES COMPLETE CONFLICT OF INTEREST TRAINING AND A CONFLICT OF INTEREST DISCLOSURE ANNUALLY. THE COMPLIANCE OFFICER ENSURES EMPLOYEES MEET THESE REQUIREMENTS AND REVIEWS SUBMITTED DISCLOSURES. DISCLOSURES IDENTIFIED AS AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST ARE ADDRESSED BY THE COMPLIANCE OFFICE WITH INVOLVEMENT OF THE INSTITUTIONAL CONFLICT OF INTEREST COMMITTEE AS APPROPRIATE. DEPENDING ON THE FACTS AND CIRCUMSTANCES, THE ACTIVITY MAY BE MANAGED PURSUANT TO A MANAGEMENT PLAN, OR PROHIBITED. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE BOARD'S COMPENSATION COMMITTEE COMMISSIONS ANNUAL THIRD PARTY SALARY SURVEYS TO DETERMINE COMPENSATION FOR THE FOLLOWING OFFICERS: CHIEF EXECUTIVE OFFICER, SCIENTIFIC DIRECTOR, CANCER CENTER DIRECTOR, CHIEF ADMINISTRATIVE OFFICER, CHIEF FINANCIAL OFFICER, CLINICAL DIRECTOR, CHIEF GOVERNANCE OFFICER/CORPORATE SECRETARY, AND CHIEF LEGAL OFFICER. IN ADDITION, FIVE EMPLOYEES ARE CONSIDERED "DISQUALIFIED" BECAUSE THEY ARE FORMER EXECUTIVES OR RELATIVES OF CURRENT OR FORMER EXECUTIVES, AND THEIR COMPENSATION THEREFORE FALLS WITHIN THE COMPENSATION COMMITTEE'S PURVIEW. ALL CHANGES TO OFFICERS' SALARIES ARE APPROVED BY THE COMPENSATION COMMITTEE AND REPORTED TO THE BOARD. THE LAST REVIEW WAS COMPLETED IN NOVEMBER 2017. |
| FORM 990, PART VI, SECTION C, LINE 19 | FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST, GOVERNING DOCUMENTS AND THE CONFLICT OF INTEREST POLICY ARE MADE AVAILABLE ONLY AS REQUIRED BY APPLICABLE STATE LAW. |
| FORM 990, PART XI, LINE 9: | CHANGE IN INTEREST IN UNRESTRICTED NET ASSETS OF ALSAC 557,070,266. CHANGE IN INTEREST IN NET ASSETS OF ALSAC 101,014,399. |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp (4 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Total IncomeTotalIncomeAmt | End Of Year AssetsEndOfYearAssetsAmt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt |
|---|---|---|---|---|---|---|---|---|---|
| CHILDREN'S GMP LLC | |||||||||
| 262 DANNY THOMAS PLACE | MEMPHIS | TN | 381053678 | 474475625 | VACCINE MANUFACTURER | TN | -$3,739,217 | $1,127,837 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC |
| THANKS & GIVING LLC | |||||||||
| 262 DANNY THOMAS PLACE | MEMPHIS | TN | 381053678 | 201310435 | ROYALTY INCOME FROM RECORD SALES | TN | $0 | $10,632 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC |
| THE RIGHT WORDS LLC | |||||||||
| 262 DANNY THOMAS PLACE | MEMPHIS | TN | 381053678 | 954878579 | ROYALTY INCOME FROM BOOK SALES | NY | $0 | $0 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC |
| ST JUDE CHILDREN'S RESEARCH HOSPITAL GRADUATE SCHOOL OF BIOMEDICAL SCIENCES | |||||||||
| 262 DANNY THOMAS PLACE | MEMPHIS | TN | 381053678 | 813240987 | HIGHER EDUCATION | TN | $0 | $0 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC |
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES INC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 501 ST JUDE PLACE | AddressLine1Txt |
| City | MEMPHIS | CityNm |
| State Abbreviation | TN | StateAbbreviationCd |
| ZIP | 38105 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 351044585 | EIN |
| Primary Activities | SOLICIT SUPPORT FOR THE OPERATION OF ST. JUDE | PrimaryActivitiesTxt |
| Legal Domicile State | IL | LegalDomicileStateCd |
| Exempt Code Section | 501(C)(3) | ExemptCodeSectionTxt |
| Public Charity Status | 7 | PublicCharityStatusTxt |
| Direct Controlling NA | N/A | DirectControllingNACd |
| Controlled Organization | 0 | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | 0 | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (1) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | Yes (1) | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (1) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | 0 | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (1) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (1) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |